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ABSTRACT 
 
 
Aims: We sought to identify differences in pain management between two groups: 
nursing home residents with malignant cancer and dementia with and without hospice 
services. 
 
Methods: Decedent records from 2003-2009 were assessed for diagnosis of 
dementia and cause of death as cancer. Ten malignant cancer diagnoses were determined 
a priori from the CDC 2004 data on the top 10 malignant cancers for all races and 
genders. Fifty-five decedents from 10 nursing homes were included in the final sample. 
Four instruments were used: Minimum Data Set (MDS) a standardized assessment tool 
required of most U.S. nursing homes. A large comprehensive assessment is conducted 
yearly followed by smaller quarterly assessments. The MDS collects demographic and 
diagnostic variables, as well as clinical, functional, psychosocial, and cognitive 
assessments. Cognitive Performance Scale (CPS scored from 1 borderline-intact to 6 very 
severe impairment); Discomfort Behavior Scale (DBS scored from 0 no discomfort 
behavior identified to 102 maximum identifiable discomfort behavior); and Equivalent 
Dose Units (EDU’s) of opioid analgesic calculated and totaled over the last 2 weeks of 
life. We calculated the CPS score from the admission MDS because we believed 
cognitive levels were unlikely to improve over time. DBS scores were calculated from 
the last MDS prior to death in an effort to capture active cancer pain at the end-of-life. 
We realized the last MDS assessment might have been in the previous 90 days. The study 
received exempt status from the office of human protection. 
 
Results: Total EDU’s were significantly greater among hospice enrollees (U 226.5, 
p <.05). There is a significantly greater likelihood of being prescribed a scheduled 
narcotic analgesic (OR 5.5; 95% CI 1.8-18.8) and a PRN narcotic analgesic (OR 3.6; 
95% CI 1.2-11.3) when enrolled in hospice. Nursing home residents not enrolled in 
hospice had a significantly (U 195.0, p < .01) lower CPS scores than those enrolled in 
hospice. Decedents with lower cognitive levels were more likely (OR 4.9; 95% CI 1.6-
15.6) to have a DBS score of zero. Forty percent of decedents with metastatic cancer and 
dementia received no opioid during the last 2 weeks of life. 
 
Conclusions: We have demonstrated that pain among nursing home residents with 
dementia and cancer is a serious problem. Forty percent of our decedents received no 
opioid at the end of life. None (n = 12) of the subjects identified in the lowest CPS score 
(6) category were enrolled in hospice. One reason appears to be blunted pain related 
behaviors. Among the severely cognitively impaired whose pain behaviors become 
blunted, scheduled pain medications may be the best way to manage their pain. Pain 
behavioral tools are better suited for individuals with mild and moderate cognitive 
impairment but become less reliable in the severely cognitively impaired. New methods 
for assessing pain in this highly vulnerable population are needed.  
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CHAPTER 1.  INTRODUCTION 
BACKGROUND 
The nursing literature has long reported that nursing home residents do not 
consistently receive high-quality palliative care (Hanson, Sengupta, & Slubicki, 2005), 
and that such environments can be deficient in end-of-life treatment (Munn, Hanson, 
Zimmerman, Sloane, & Mitchell, 2006; Reynolds, Henderson, Schulman, & Hanson, 
2002). In particular, the management of pain at the end of life for nursing home residents 
could be much improved (Buchanan, Choi, Wang, & Ju, 2004; Hoffman & Tarzain, 
2005); many die from conditions that cause substantial physical distress. Such residents 
would be well served by enrollment in hospice services, warranted when the patient has a 
fatal illness and requires close attention to pain management. According to one study, 
only a little more than a third (37.1%) of nursing home residents with dementia who had 
a terminal diagnosis had daily pain or frequent pain suitable for hospice services 
(Mitchell, Morris, Park, & Fries, 2004). In contrast, Munn et al. (2006) reported that 
residents enrolled in hospice services were 22% more likely to receive pain treatment.  
 
Currently 20% to 24% (Ersek & Wilson, 2003; Hanson, Reynolds, Henderson, & 
Pickard, 2005) of all deaths in the U.S. occur in nursing homes, which means that each 
year approximately 480,000 to 821,000 people expire in such facilities. Researchers 
suggest that these percentages will double by the year 2040 (Ersek & Wilson, 2003). The 
annual mortality rate in nursing homes varies from 24% to 32% (Dobbs, Hanson, 
Zimmerman, Williams, & Munn, 2006), and first-year mortality rates hover around 34% 
(Munn, et al., 2006). Investigators have found that nearly 50% of the nursing home 
population has dementia (Magaziner, et al., 2000). Clearly, significant numbers of older 
adults live and die in nursing homes. Increasing the quality of life at the end of life 
among nursing home residents, especially those with dementia, is a challenge. 
 
While a patient’s self-reports are the accepted standard in pain assessment, 
nursing home residents with cognitive impairment (CI) are frequently unable to 
understand and report pain, and thus such self-reports may be unreliable. This situation is 
complicated by the presence of depression or dementia, which can directly affect 
residents’ perceptions.  
 
Nurses experienced in long-term care or family members may well be able to 
offer assessments of a resident’s pain through proxy pain ratings (McCaffery, 1999), but 
such accounts by individuals close to the resident often reflect their beliefs and emotional 
reactions to the situation. Another challenge to the accurate assessment of pain is that the 
typical signs associated with acute pain are not useful indicators in older adults, and 
currently no biological markers exist to assess pain (Davis & Srivastava, 2003). Further, 
without a subjective report of pain, there can be no pain intensity rating (Pasero & 
McCaffery, 2005).  
 
The use of hospice services to assist in the appropriate and effective management 
of pain among nursing home residents with CI may facilitate a more dignified death. 
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Hospice entails an interdisciplinary approach, addressing a patient’s physical, sociologic, 
spiritual, and psychogenic symptoms. In one study, nursing home residents identified 
indicators of such a death as the maintenance of social networks, not becoming a burden 
to others, staying active, not being in pain, and respecting one’s wishes to pass on 
(Pleschberger, 2007). Highly trained hospice staff offer a number of services, including 
pain management at the end of life (Hoffman & Tarzain, 2005). Given a median survival 
time of 4 months and a mean survival time of 6.3 months for nursing home residents with 
severe dementia (Luchins, Hanrahan, & Murphy, 1997), hospice services seem 
particularly appropriate for such patients (Cherney, 2008). Such services may offer the 
nursing home staff and residents’ families support while simultaneously helping older 
adults with severe CI manage pain and ease the transition from life to death. 
 
 
PURPOSE 
The purpose of this study was to identify the differences in pain medication 
administration between two different groups of deceased subjects, nursing home residents 
with malignant cancer and dementia with and without hospice services. 
 
 
SPECIFIC AIMS 
The aims that guided this study were derived from the literature and are described 
next; associated hypotheses follow each study aim. 
 
 
Specific Aim One 
 Specific Aim One was to determine the differences in administered pain 
medications for cognitively impaired residents who died from cancer while receiving 
hospice services as compared with those not receiving hospice services. The following 
eight hypotheses were associated with this aim.  
 
 Hypothesis 1. Residents who received hospice services would receive more 
scheduled narcotic analgesic than residents who did not receive hospice 
services. 
 Hypothesis 2. Residents who received hospice services would receive greater 
total equivalent dose units (EDU’s) of narcotic analgesic than residents who 
did not receive hospice services.   
 Hypothesis 3. Residents who received hospice services would receive greater 
total dose number of non-narcotic analgesics (TDNN) than residents who did 
not receive hospice services.   
 Hypothesis 4. Residents who received hospice services would receive more 
PRN narcotic analgesic than residents who did not receive hospice services. 
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 Hypothesis 5. Residents who received hospice services would receive more 
scheduled non-narcotic analgesic than residents who did not receive hospice 
services. 
 Hypothesis 6. Residents who received hospice services would receive more 
PRN non-narcotic analgesic than residents who did not receive hospice 
services.   
 Hypothesis 7. Residents who received hospice services would have different 
cognitive performance scores (CPS) than residents who did not receive 
hospice services.  
 Hypothesis 8. Residents who received hospice services would receive greater 
total dose numbers of drug potentiators (TDNP) than would residents who did 
not receive hospice services.  
 
Specific Aim Two 
Specific Aim two was to determine if discomfort related pain behaviors among 
nursing home residents with cancer and dementia decrease with increasing cognitive 
impairment. The following hypothesis is associated with this aim. 
 
Hypothesis 9. Discomfort related pain behaviors among all residents will be 
decreased with increasing cognitive impairment. 
 
 
CONCEPTUAL FRAMEWORK 
Hospice is an interdisciplinary healthcare practice with an emphasis on addressing 
the terminally ill patient’s physical, sociologic, spiritual, and psychological symptoms. 
Hospice is warranted when a nursing home resident has an irreversible, progressive 
illness and is near the end of life. Hospice was founded on 10 basic principles 
(Connecticut Hospice, 1998) (Figure 1-1) including: the family and patient are 
considered the unit of care, an interdisciplinary team provides care, 24 hour availability 
of professional assistance, with a primary goal of pain relief and management of 
associated symptoms (Parham, 2002).  
 
The hospice philosophy incorporates the biopsychosocial paradigm. Several 
assumptions about the origin of pain are integrated into the biopsychosocial approach 
(Davis & Srivastava, 2003; Gatchel, 2004; Killinger, Morley, Kettner, & Kauric, 2001). 
In this model, biological, mental health, and socio-environmental variables combine to 
create the pain experience and thus all require attention when treatment is planned.  
 
This conceptual framework guided the research question that nursing home 
residents with malignant cancer and dementia with hospice may have different pain 
management than those who did not receive hospice services. 
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1. The patient and family are regarded as the unit of care. 
2. Services are physician directed and nurse coordinated. 
3. Emphasis is on control of symptoms (physical, sociologic, spiritual, and 
psychogenic). 
4. An interdisciplinary team provides care. 
5. Trained volunteers are an integral part of the team. 
6. Services are 24 hours a day, 7 days a week, on call, with emphasis on availability of 
medical and nursing skills. 
7. Family members receive bereavement follow-up. 
8. Home care and inpatient care are coordinated. 
9. Patients are accepted on the basis of health needs, not on ability to pay. 
10. There are structured systems for staff support and communication 
 
Figure 1-1.  10 Principles of Hospice Care 
Source: Modified with permission from Connecticut Hospice (1998). 10 principles of 
hospice care. Cancer Therapeutics, 1(2), 11. 
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DEFINITIONS 
 The definitions that follow were used to conceptually guide and operationally 
define various components of this research. 
 
 Cancer. Any one of 10 malignant ICD-9 cancer codes established a priori and 
a confirmatory diagnosis of cancer in the medical record. These included colo-
rectal, female breast, prostate, lung, uterine, melanoma of the skin, ovarian, 
kidney, non-Hodgkin’s lymphoma, and bladder. 
 
 Dementia. For the purposes of this study dementia was defined as a diagnosis 
of Alzheimer’s disease (Dementia of the Alzheimer’s Type or DAT), Lewy 
body dementia, vascular dementia, or mixed as recorded in the medical 
record.  
 
 Hospice. Enrollment in a Medicare approved hospice program as recorded in 
the medical record. 
 
 Minimum Data Set (MDS). An assessment instrument required in all long-
term care facilities that receive federal Medicare/Medicaid funds. 
 
 Discomfort. For the purposes of this retrospective study we define discomfort 
behaviors as those behaviors that may indicate physical discomfort or pain. 
Therefore the terms “discomfort” and “pain” in this study are used 
interchangeably. 
 
 
ASSUMPTIONS 
 This study involves a retrospective analysis of patient chart information, and as 
such a major assumption is that these records will be accurate.  
 
 
LIMITATIONS 
As noted above, the author assumes that all data in the medical record were 
accurate; therefore, the first major limitation is that some information may not be 
accurate. The record may not reflect the actual care the resident the received. The nurse 
who administered care to the resident may not have recorded the MDS data. A diagnosis 
of malignant cancer does not necessarily mean the individual had active cancer upon 
death, however every effort to ensure active cancer was made and if undeterminable, the 
subject was not considered for this study. The nurse providing the care is most often an 
LPN and the MDS must be signed by an RN who may or may not have completed the 
form. 
 
There were limitations in this retrospective study design. The convenience sample 
was selected over six years with multiple providers coding the MDS data and charting 
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diagnoses and medication administration. The MDS has been identified with limitations 
when used as a research tool (Mentes, Culp, Maas, & Rantz, 1999; Ryan, Stone, & 
Raynor, 2004) and this potentially weakens the study findings. 
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CHAPTER 2.  REVIEW OF THE LITERATURE 
COGNITIVE IMPAIRMENT 
 
Defining Cognitive Impairment 
 Carr, Duchek, Meuser, and Morris (2006) define CI as a “decline in at least one of 
the following areas: short-term memory, attention, orientation, judgment and problem-
solving-skills, and visuospatial skills.” The Geriatric Research Group (n.d.)  has defined 
CI as “short-term memory loss and difficulty finding words.”  Mild CI has been defined 
as “cognitive deficits that fall short of the diagnostic criteria for dementia” (Carr, et al., 
2006, p. 1029). Additionally, mild CI has been defined as impairment without dementia 
or functional impairment (Plassman, et al., 2008).  
 
 
Measuring Cognitive Impairment  
 The Cognitive Performance Scale (CPS) (Morris, et al., 1994) was developed from 
five MDS items and is reported both reliable and valid when an individual is trained on 
its use (Paquay, et al., 2007). Wu and colleagues (2003) quantified the severity of 
cognitive impairment with the CPS into three categories, no or mild CI (0-1), moderate 
CI (2-3), and severe CI (4-6). They reported that scores of 4-6 have been reported to 
correlate with a MMSE score of <10, indicating severe CI while CPS scores of 5 and 6 
are equivalent to an MMSE of <5 (Hartmaier, et al., 1995; Morris, et al., 1994) indicating 
very severe impairment. 
 
 
Etiology and Pathophysiology 
 The presence of the apoliopoprotein E-4 (APOE-4) gene and cardiovascular risk 
factors and hypertension have a direct association with dementia of the Alzheimer’s type 
and vascular dementia Other genetic precursors have been identified, the APP and three 
other APOE alleles (APOE e1, e2, and e3) and the presenilins (Beatty, 2006). All of the 
APP genes lead to the production of A-beta 42, a neurotoxic amino acid sequence, which 
has been implicated in the formation of amyloid plaques (Beatty, 2006).  It is 
hypothesized that amyloid plaques occur first in the pathology of dementia of the 
Alzheimer’s type (Beatty, 2006).  
 
 
Dementia of the Alzheimer’s Type (AD) 
 
The pathopysiology of Alzheimer’s disease is not exactly known. Several theories 
are being investigated, 1) loss of neurotransmitter stimulation by choline 
acetyltransferase; 2) mutation for encoding amyloid precursor protein; 3) alterations in 
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apoliopoprotein E, which binds beta amyloid; and 4) pathologic activation of N-methyl-
D-asparate (NMDA) receptors resulting in an influx of excess calcium (Alzheimer's 
Association, 2008).  
 
Each of these theories is linked to the formation of insoluble amyloid plaques in 
brain tissue and blood vessels. AD has also been linked to the breakdown of lysosomal 
pathways. These pathways are the precursor protein to yield beta amyloid, a neurotoxic 
substance coded by chromosome 21 (McCance & Huether, 2006). Another theory is that 
once the plaques form, complement proteins attach to them, attracting microglia (the 
brains immune force), which release toxins in an attempt to destroy the plaques creating 
an endless cycle (Alzheimer's Association, 2008).  
 
Additional destruction of brain tissue results when the stabilizing tau proteins 
detach from microtubules and form insoluble helical filaments called neurofibrillary 
tangles (McCance & Huether, 2006). Further damage occurs in cerebral arteries where 
amyloid is deposited and groups of nerve cells degenerate around this deposited amyloid 
core (Alzheimer’s Association, 2008). Microscopic examination reveals senile plaques, 
which disrupt nerve impulse transmission (Alzheimer's Association, 2008). The greater 
the number of senile plaques and tangles the more dysfunction associated with AD 
(McCance & Huether, 2006).  
  
 
Vascular Dementia 
Multi-infarct dementia is a common form of dementia and is thought to be a 
combination of: 1) vascular mild cognitive impairment, 2) multi-infarct dementia, 3) 
vascular dementia due to a strategic single infarct (affecting the thalamus, the anterior 
cerebral artery, the parietal lobes or the cingulate gyrus), 4) vascular dementia due to 
hemorrhagic lesions, 5) small vessel disease (which includes vascular dementia due to 
brain lesions and Binswanger's disease), and 6) mixed Alzheimer's and vascular dementia 
(Alzheimer's Association, 2008; Alzheimer's Society, 2008). 
 
Vascular lesions can be the result of diffuse cerebrovascular disease or focal 
lesions (or a combination of both, which is what is observed in the majority of cases). 
Mixed dementia is diagnosed when patients have evidence of AD and cerebrovascular 
disease, either clinically or based on neuroimaging evidence of ischemic lesions 
(Alzheimer's Association, 2008; Alzheimer's Society, 2008).  
 
 
Lewey Body Dementia 
Lewy Body Dementia (LBD) exhibits clinical overlap between Alzheimer's 
disease and Parkinson's disease (McCance & Huether, 2006). Lewy bodies present as 
round masses that displace other cell components (Alzheimer’s Association, 2008). There 
are two types: classical (brain stem) Lewy bodies and cortical Lewy bodies. Conventional 
Lewy bodies are eosinophilic cytoplasmic enclosures that consist of dense cores 
surrounded by halos of 10-nm wide radiating fibrils (McCance & Huether, 2006), the 
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primary structural component of which is alpha-synuclein, whereas a cortical Lewy body 
is less well-defined and lacks the halo (McCance & Huether, 2006). When Lewy body 
inclusions are found in the cortex, they often co-occur with Alzheimer's disease including 
neurofibrillary tangles (abnormal tau protein) and senile plaques (deposited beta-amyloid 
protein) (Alzheimer's Association, 2008; Alzheimer's Society, 2008). 
 
Within LBD, the loss of cholinergic (acetylcholine-producing) neurons is thought 
to account for the degradation of cognitive and emotional functioning as in AD, while the 
loss of dopamine-producing neurons is thought to account for the degradation of motor 
control as in Parkinson's disease (McCance & Huether, 2006).  
 
 
Differentiation between Dementia and Delirium 
 Nursing literature often uses the terms cognitive impairment, dementia, delirium, 
and confusion. This study is concerned with nursing home residents with a diagnosis of 
dementia, including Alzheimer’s disease. The American Psychiatric Association defined 
dementia as the “loss of intellectual abilities (medically called cognitive function) of 
sufficient severity to interfere with social or occupational functioning” (Maslow & 
Mezey, 2008; World Health Organization, 2006). Intellectual abilities include memory 
and learning, attention, concentration and orientation, thinking (e.g., problem solving, 
abstraction), calculation, language (comprehension, word finding), and geographic 
orientation. According to the World Health Organization (2006), “Dementia leads to a 
loss in all [emphasis added] of these cognitive abilities . . . . Dementia is a loss of 
multiple components of intellectual function . . . . Contrary to popular belief, loss of 
memory is not the only deficit in dementia.” For Bjoro and Herr (Bjoro & Herr, 2008), 
dementia involves the development of multiple cognitive losses, loss of language, ability 
to recognize or identify objects, and executive function. In other words, dementia results 
in a significant loss of intellectual abilities severe enough to interfere with social or 
occupational functioning.   
 
Dementia and delirium should be considered different diagnoses (Beatty, 2006), a 
point summarized well by Herr and Garand (2001, p. 463) who define delirium as “acute 
confusion” and dementia as “chronic confusion.” For Barrie (2002, p. 29), dementia is a 
worsening of intellectual function leading to a decline in the ability to perform activities 
of daily living and the most common cause (60%) of dementia is Alzheimer’s disease 
often called senile dementia.  The Geriatric Research Group (n.d.) offers another 
definition:  “[Dementia is] a common clinical syndrome characterized by decline in 
cognitive function from previously attained intellectual level that is sustained for months 
or years.” Other causes of dementia include vascular dementia 10%, and Pick’s disease, 
Parkinson’s disease, and Cruetzfeldt-Jacob disease cause a small fraction of cases. 
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PAIN AND DEMENTIA 
 
Determining the Presence of Pain in Severe Dementia 
Questions have arisen as to whether Alzheimer’s disease alters the processing of 
pain by the brain. Individuals with DAT receive fewer analgesics and report less pain 
than cognitively intact controls (Cook, Niven, & Downs, 1999; Farrell, Katz, & Helme, 
1996; Frampton, 2003). However, it remains unclear if differences in analgesic intake or 
self report result from impaired communication, impaired memory, or impaired 
perception of pain resulting from alterations in pain transmission in the brain (Farrell, et 
al., 1996; Scherder & Bouma, 1997; E. Scherder, et al., 2003; Scherder, et al., 2005). 
Questions arise whether the lower level of pain medication is because of less pain or 
because clinicians are not adequately managing pain in patients with severe DAT. 
Evidence does not currently exist determining if the pathways in the brain of individuals 
with severe DAT are intact (Cole, et al., 2006) and this question must be addressed in 
order to establish evidenced based nursing care (Algase, 2006; Harvath, et al., 2006).  
 
In 1990, functional mapping of the human brain using venous blood oxygenation 
level-dependent (BOLD) magnetic resonance imaging contrast was developed (Ogawa & 
Lee, 1990; Ogawa, Lee, Nayak, & Glynn, 1990). The BOLD contrast relies on changes in 
deoxyhemoglobin levels in the blood as the endogenous magnetic contrast agent (Ogawa, 
et al., 1990). This means that changes in deoxyhemoglobin levels in the brain cause 
changes in the MRI signal leading to functional brain mapping or fMRI (Ogawa & Lee, 
1990) and this mapping can describe acute pain in the brain (Davis, 2006). 
 
Pain is a subjective experience with sensory-discriminative, affective-
motivational, and cognitive-evaluative components (Melzack & Casey, 1968). Each of 
these components of pain is regulated by lateral and medial pain pathways in the brain. 
The location, intensity, and quality of pain are modulated by the lateral pain system 
consisting of the spinothalamic tract ascending from the ventro-posterior lateral thalamus 
onto the primary and secondary cortices (Bornhovd, et al., 2002; Cole, et al., 2006). The 
medial pathway, a second major pain pathway, branches at the medulla and ascends via 
the medial thalamus to the hypothalamic nuclei, limbic regions (cingulate cortex), insula 
cortex and then onto the prefrontal areas which are involved in the control of emotion, 
arousal, and attention (Bornhovd, et al., 2002; Cole, et al., 2006; Craig, n.d.; Davis, 
2006). The medial pathway is believed to mediate the unpleasant, affective dimension, 
and the response to noxious stimulus (Bornhovd, et al., 2002; Price, 2000; Treede, 
Kenshalo, Gracely, & Jones, 1999). Further evidence from fMRI (Thompson, Hayashi, 
de Zubicaray, & Jones, 2003) and pathology (Rub, Del Tredici K, Del Turco, & Braak, 
2002) suggests that the neurodegenerative changes in DAT affect the medial pain system 
and yet the lateral pain tract is preserved (Scherder & Bouma, 1997, 2000).  
 
These findings suggest that individuals with DAT have pain, but may not be able 
to express it. Research among cognitively intact individuals using fMRI has been able to 
discern between lateral and medial pain pathways demonstrating sensory and emotional 
pain perception (Bingel, et al., 2002; Bornhovd, et al., 2002). This means that very 
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severely cognitively impaired older adults (CIOA) may be able to feel the pain but be 
unable to verbalize or express it through physical behaviors.  
 
The prevalence of painful conditions increases in clinical settings (Hutt, Pepper, 
Vojir, Fink, & Jones, 2006; Marzinski, 1991; Scherder, Bouma, Borkent, & Rahman, 
1999) and administration of analgesic medication decrease as cognitive impairment 
increases (Cook, et al., 1999; Frampton, 2003; Herr, Mobily, Kouhout, & Wagner, 1998; 
Monroe, 2010; Scherder & Bouma, 2000). This decrease in medication occurs despite the 
fact that the pain threshold does not differ between mild and moderately CIOA and the 
intact (Cole, et al., 2006). Gibson and colleagues (2001) used EEG to show that peak 
amplitude CNS activated evoked potentials are not diminished among verbally 
communicative subjects with DAT. A limitation of EEG studies is that while cortical 
processing of noxious stimulus is present, spatial resolution is not possible, limiting the 
conclusions about how the disease may alter pain-related CNS processing (Cole, et al., 
2006). Cole and colleagues (2006) used fMRI to study the pain pathways among verbally 
communicative individuals with mild to moderate DAT and found that both lateral and 
medial pain pathways were preserved. 
 
 
Current Theories Explaining Decreased Pain in Persons with Dementia 
Farrell et al (1996) suggested that language and memory problems might 
confound reports of pain. Scherder et al (2003) proposed that the neuropathology 
associated with dementia changes the experience of pain through interruption of 
neurological transmission. A second neuropathology theory is that the formation of toxic 
mediators results in out of control inflammatory responses potentially inhibiting or 
destroying transmissions (Mulugeta, et al., 2008). Damage to different areas of the brain 
has been associated with both increases and decreases in pain intensity and effect 
(Melzack & Wall, 1988) and different types of dementia may be associated with different 
types of pain experience (Scherder, Sergeant, & Swaab, 2003). The theory of altered 
autonomic nervous system response has been studied. Cognitively impaired individuals 
showed blunted heart rate and blood pressure in response to noxious stimuli compared to 
matched controls (Benedetti, et al., 1999; Rainero, Vighetti, Bergamasco, Pinessi, & 
Benedetti, 2000). However, there were no differences between groups at more intense 
levels of stimulation (Rainero, et al., 2000). Much of this work has been conducted on 
acute pain and presently there is not sufficient empirical evidence to support any one 
theory.  
 
 
PAIN IN COGNITIVELY IMPAIRED NURSING HOME RESIDENTS 
In 1979, Margo McCaffery (1999, p. 8) defined pain as “Whatever the 
experiencing person says it is, existing where ever he says it does.” The International 
Association for the Study of Pain provides one widely accepted definition of pain:  “An 
unpleasant sensory and emotional experience associated with actual or potential tissue 
damage, or described in terms of such damage (International Association for the Study of 
Pain, 1979). The subjective nature of pain is well characterized by (Johansson, Hamburg, 
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Westman, & Lindergren, 1999, p. 1791). “The main difficulty is that [pain] is a person’s 
private experience, to which no one else has direct access”  
 
Dementia of the Alzheimer’s Type (DAT) is the most common cause of dementia 
(Alzheimer's Association, 2009) The number of persons with DAT in the United States is 
estimated between 4 to 6 million (Alzheimer's Association, 2009; Hebert, Scherr, 
Bienias, Bennett, & Evans, 2003) and current estimates are that DAT cases will grow to 
16 and 17 million by the year 2050 (Alzheimer's Association, 2009; Hebert, et al., 2003). 
Beatty (2006) reports that 10% of adults over the age of 65 and 50% over the age of 90 
have dementia, while Chung (2006) estimated that 4-12% of older adults have dementia 
and/or cognitive impairment (CI).  
 
Many older adults do not receive adequate pain management. Between 40% and 
80% of community-dwelling older adults (Pahor, et al., 1999; Woo, Ho, Lau, & Leung, 
1994) and 16% and 25% of nursing home residents (Feldt, Ryden, & Miles, 1998; Horgas 
& Tsai, 1998; Lichtenberg & McGorgan, 1987) receive no pain medication. Bernabei and 
colleagues (1998) found that 25% of elderly patients who reported daily pain received no 
analgesics. 
 
Cognitively intact individuals can report their pain and nurses can then intervene. 
However, we have known for several years that individuals with mild, moderate, or 
severe cognitive impairment present specific assessment and management problems for 
nurses (Beck, et al., 1998; Happ, 2000; Harvath, 1994; Kolanowski, Litaker, & Buettner, 
2005) with many individuals unable to self-report pain  (Feldt, et al., 1998; Ferrell, 
Ferrell, & Rivera, 1995; Hadjistavropoulos, Craig, Martin, & et al., 1997; Horgas & 
Miller, 2008; Tsai, et al., 2008) For example, Weiner (1998) reported that only 30-50% 
of adult day care participants with mild and moderate CI could report pain. Self-report 
becomes impossible as dementia progresses because individuals lose the ability to 
communicate.  
 
Assessment using behavioral markers becomes unreliable among individuals with 
severe CI (Gagliese, 2001; Herr, Bjoro, & Decker, 2006; McCann, Gilley, Hebert, 
Beckett, & Evans, 1997; Monroe & Carter, 2009) because severe CI blunts behaviors 
(Beck, et al., 1998; Monroe & Carter, 2009; Reisberg, 1984; Stevenson, Brown, Dahl, 
Ward, & Brown, 2006). Assessment relaying on verbal reports becomes unreliable 
because severe CI blunts speech (Farrell, et al., 1996; Herr, et al., 2006). Therefore, 
nurses do not have clear evidence-based methods to assess and manage pain in the very 
severely cognitively impaired older adults and evidence based practice is necessary in 
order to sustain the profession of nursing (Algase, 2006). 
 
 Drawing generalizations from the nursing literature with regard to pain 
assessment and gauging a resident’s mental status is problematic, however, since few 
authors accurately distinguish dementia, CI, and CI without dementia. For example, 
Ferrell, Ferrell, and Rivera (1995, p. 597) comment that “Cognitive impairment 
(dementia or delirium) is a substantial barrier to pain assessment in this population.” Here 
the authors imply that CI is equivalent to dementia or delirium, when in fact CI is one 
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facet of a differential diagnosis of dementia. Therefore, it would be useful to provide 
specific definitions of those conditions pertinent to this study, CI and dementia. 
 
 
HISTORY OF HOSPICE 
 Dr. Cicely Saunders began modern hospice at St. Christopher’s near London in 
the 1960’s as the first program to use aggressive pain management for dying individuals. 
Dr. Saunders believed in effective symptom control, caring for the individual, and family 
(Marx, 2007; Parham, 2002).    
 
In 1963, Dr. Saunders visited Yale University where she presented her model to a 
group of healthcare professionals including the Dean of the Yale School of Nursing, 
Florence Wald. Dr. Wald was so impressed she began working to bring hospice to the 
United States (Parham, 2002). During this time, Elisabeth Kubler-Ross published On 
Death and Dying based on hundreds of interviews with dying patients. Kubler-Ross 
believed that individuals had the right to die at home. Ultimately through their efforts, 
Hospice came to the United States in 1974 located in New Haven, Connecticut and in 
1977 the National Hospice Organization (NHO) was founded (Parham, 2002).  
 
 
ASSESSING PAIN IN NURSING HOME RESIDENTS WITH COGNITIVE 
IMPAIRMENT 
 
Instruments 
 The Discomfort Behavior Scale (DBS) (Stevenson, et al., 2006) was developed as 
an alternative to self-report and surrogate pain ratings for older adults with cognitive 
impairments. The DBS is a 17-item instrument derived from assessment items on the 
Minimum Data Set (MDS) 2.0 (U. S. Department of Health and Human Services, 
2000a) that address behaviors that may indicate discomfort related pain. The MDS is a 
comprehensive tool that is used to assess all residents in U.S. nursing homes. The 
assessment includes demographic and diagnostic variables, as well as clinical, functional, 
psychosocial, and cognitive assessments. Full MDS assessments are required at the time 
of admission and on the annual anniversary of admission. Shorter assessments are 
completed quarterly and following significant changes in the resident’s status (U. S. 
Department of Health and Human Services, 2000a).  Clinicians and care providers should 
be aware of biases and inconsistencies occurring from surrogate pain ratings (Engle, 
Graney, & Chan, 2001; Horgas & Dunn, 2001) such as those required for the initial MDS 
assessment, the State of the Art Review of Tools for Assessment of Pain in Nonverbal 
Older Adults (as cited in Herr, Bursch, Miller, & Swafford, 2010). This means that the 
reliability of the DBS is dependent on the potential variability inherent in the MDS. 
 
 Initial conceptualization of the DBS was developed with four experts in pain 
assessment in cognitively impaired older adults reviewing the content validity of the 
DBS. Item construction was taken from specific MDS data believed to be behavioral 
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indicators of discomfort and potentially discomfort related pain. Content validity was 
established by reviewing 20 MDS items; 8 from section E1 (indicators of depression, 
anxiety or sad mood), 10 from section E4 (indicators of behavioral problems such as 
wandering or resisting care), and 2 from section G1 (self performance such as ability to 
walk) (Herr, Bursch, & Black, 2008; Stevenson, et al., 2006). There was 100% agreement 
on 19 items and 2 other items related to walking were dropped because they would bias 
non-mobile residents (Herr et al., 2008). 
 
 Next, exploratory (EFA) and confirmatory (CFA) factor analysis were conducted 
to confirm single discomfort factor dimension. This single dimension was then confirmed 
in a third sample to confirm the DBS score (Stevenson et al., 2006). EFA demonstrated a 
single discomfort dimension with a goodness of fit .068. Eigenvalue structure indicated 
42.4% of the variance explained by the single discomfort dimension (Herr, et al., 2008; 
Stevenson, et al., 2006). CFA with second sample supported the construct of a single 
discomfort dimension with CFI = 0.977, TLI = 0.974, and RMSEA = 0.068 (Stevenson, 
et al., 2006). The third sample used to test the model demonstrated good fit with CFI = 
0.955, TLI = 0.955, and RMSEA = 0.087.  
 
 Composite reliability of the DBS was .98, with a Chronbach’s alpha of .77 and a 
shared variance of .76 (Stevenson, et al., 2006) indicating that only 24% of the average 
variance is related to error (Herr, et al., 2008; Stevenson, et al., 2006). Interrater or 
Intrarater reliability was not reported in the original study. The authors found each item 
in the DBS to be tau equivalent with good internal consistency (Stevenson, et al., 2006). 
The DBS is scored from 0 – 102 and factor analysis showed that the DBS is able to 
discern a single discomfort dimension (Stevenson, et al., 2006). The original study (N = 
29,120) was a large epidemiologic study of cognitively impaired individuals in 
Wisconsin, USA using the MDS 2.0 (Stevenson, et al., 2006).  
 
 Stevenson and colleagues (Stevenson, et al., 2006)compared DBS scores with 
categorical Cognitive Performance Scale (CPS) scores. The CPS is a reliable and valid 
measure of cognitive decline that also uses specific MDS items (Paquay, et al., 2007). 
The CPS is scored from 1 (borderline intact) to 6 (very severe impairment). Stevenson 
and colleagues studied moderate to very severe impairment (CPS 3 – 6) and found that 
DBS scores increased with increasing levels of cognitive impairment, except for the 
highest level of impairment (CPS = 6) and hypothesized that severe CI may blunt the 
outward signs of discomfort (Stevenson, et al., 2006).  
 
 The Cognitive Performance Scale (CPS) (Morris, et al., 1994) was developed 
from five MDS items and is reported both reliable and valid when an individual is trained 
on its use (Paquay, et al., 2007). The CPS is scored from 1 to 6 indicating borderline 
intact to very severe impairment. Wu and colleagues (2003) quantified the severity of 
cognitive impairment with the CPS into three categories, no or mild CI (0-1), moderate 
CI (2-3), and severe CI (4-6). They reported that scores of 4-6 have been reported to 
correlate with a MMSE score of <10, indicating severe CI while CPS scores of 5 and 6 
are equivalent to an MMSE of <5 (Hartmaier, et al., 1995; Morris, et al., 1994) indicating 
very severe impairment. 
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Feldt (2000) found that older adults with CI could successfully complete basic 
verbal pain instruments and that these reports are both reliable and valid, while Stolee, et 
al. (2005) reported that completion rates on instruments that measure intensity appear to 
be highest such as the Pain Thermometer and Numerical Rating Scale. For example, they 
found that 90% of older adults with mild CI and 100% of older adults with moderate CI 
could complete the Faces Pain Scale, the Present Pain Intensity Scale (PPI), and the 
Memorial Pain Assessment Card (MPAC). Kamel, Phlavan, Malekgoudarzi, Gogel, and 
Morley (2001) confirmed the usefulness of instruments in assessing a nursing home 
resident’s specific level of pain over asking him or her for a self-report. Among residents 
given three basic instruments (verbal pain scale, visual analogue scale, and the faces 
scale), reports of pain increased 50% over those residents who were simply asked “Do 
you have pain?”  
 
 Verbal descriptor scales such as the PPI are considered advantageous for their easy 
and quick administration. However, the adjectives used in the scales may hinder the 
patient from responding, since he or she may not be able to understand or identify the 
word used as the descriptor of pain (DeWaters, 2003). Freeman et al. (2001) compared 
residents’ results in using the Visual Analogue Scale (VAS), a 0–100 mm line, and the 
Faces Rating Scale (FRS), a series of six faces.  
 
 The current state of instrument development among non-verbal and severely 
cognitively impaired individuals is in its infancy. Herr and colleagues (2006) conducted a 
state of the science review on ten pain behavior instruments. Herr and colleagues’(2006) 
review showed promise for several instruments and ultimately recommended further 
testing. Currently there is no behavior instrument with proven reliability and validity for 
use in the non-verbal and severely cognitively impaired individual (Bjoro & Herr, 2008).  
 
 
Methodological Problems Measuring Pain 
 The International Association for the Study of Pain (IASP) provides one widely 
accepted definition of pain which reads, “Pain: An unpleasant sensory and emotional 
experience associated with actual or potential tissue damage, or described in terms of 
such damage” (International Association for the Study of Pain, 1979, p. 250). The 
difficulties in the subjective nature of pain are summed up by Johansson, Hamburg, 
Westman, & Lindgren (1999, p. 1791), “The main difficulty is that [pain] is a person’s 
private experience, to which no one else has direct access.” McCaffery (1999, p. 8) 
defined pain as, “Whatever the experiencing person says it is, existing where ever he says 
it does.” If according to these recognized definitions of pain, a person must understand 
and report pain, then the person must be able to recognize and describe the experience of 
pain. This is clearly a problem for people with cognitive impairments.  
 
 How one interprets his/her own quality of pain is key in establishing reliability 
and validity in the cognitively impaired elderly person (Ferrell, Stein, & Beck, 2000). 
Feldt (2000, p. 14) summarized threats to validity when assessing pain in older persons 
with CI, “Impaired verbal skills and the ability to abstract concepts further obstruct 
assessment in pain for this population.” According to Ferrell et al. (2000, p. 1669), “Valid 
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and reliable assessment of pain relies on individual patient interpretations and self-
report.” Additionally, Feldt (2000) pointed out decreased reliability inherent in many pain 
assessment tools used in the cognitively impaired that rely on memory of previous 
painful experiences. Bjoro and Herr (2008, p. 246) stated, “Observational approaches to 
pain assessment rely on interpretations of behaviors. The inherent subjectivity involved . . 
. represents challenges to the reliability and validity of pain assessments.” As such, there 
is currently no reliable or valid observational tool recommended for clinical practice 
(Bjoro & Herr, 2008). 
 
 Pasero and McCaffery (2001) argue that the only reliable information about pain 
must come from the patient. Hanson et al. (2008) reported that among nursing home 
residents with CI, 42% could express pain verbally; Ferrell (1995) found that 62% of 
nursing home residents with mild and moderate CI were able to report pain, and 83% 
could use one of five pain instruments (Ferrell, et al., 1995). The challenge, therefore, is 
to find a reliable and valid instrument that will be useful in residents with CI who are in 
many instances nonverbal. 
 
 
Methodological Problems Measuring Cognitive Impairment 
 The Mini-Mental State Examination (MMSE) is the most frequent research and 
assessment tool for measuring CI and measuring cognitive status (Chopra, Cavalieri, & 
Libon, 2007; Tombaugh & McIntyre, 1992). There are inconsistencies and improper 
usage of the MMSE found in research literature.  
 
 The MMSE was not designed to be the sole determinant of dementia and is 
intended to be used only as a screening device for impairment (Chopra, et al., 2007; 
Decker & Perry, 2003; Folstein, 1975; Teng & Chui, 1987; Tombaugh & McIntyre, 
1992; Weiner, 1999). Screening means that dementia likely exists. The MMSE is not 
reliable in persons with less than an eighth grade education and in persons who are not 
fluent in spoken English (Tombaugh & McIntyre, 1992). Heye (1997, p. 136) pointed out 
that screening for CI can be facilitated with the MMSE but the client must be able to 
speak, hear, and see. Weissman and Matson (1999, p. 34) shared concerns with CI that 
would directly affect administration of the MMSE related to hearing, visual impairment, 
language, attention span, and cognitive ability affecting the assessment process. Lehmann 
& Rabins (1999, pp. 180-181) stressed CI should only be a part of the mental state 
examination: “The complete mental status examination, however, always [emphasis 
added] includes attention to the following areas: general appearance, speech, mood, 
suicidal ideation, abnormal thought content, and cognitive assessment.” The MMSE only 
touches on a few of these components, speech and cognitive status. 
 
 The MMSE is probably the most popular tool for measuring cognitive status 
(Chopra, et al., 2007), but it was designed to be used only as a screening device for levels 
of impairment (Chopra, et al., 2007; Folstein, 1975; Teng & Chui, 1987; Tombaugh & 
McIntyre, 1992).  There are additional issues to be addressed when using the MMSE as a 
research tool in assessing nursing home residents with CI: their educational level, sensory 
status, and language fluency, for example. Some researchers, such as Tombaugh and 
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McIntyre (1992) have suggested that comparing MMSE scores across multiple studies 
may be difficult because a variety of ranges of impairment have been used. An example 
may be 26-30 no CI, 21-25 MCI, 16-20 moderate CI and 15 or less indicating severe CI. 
 
 
SUMMARY 
 In the U.S., 25% of adult deaths each year now occur in nursing homes (30% in 
the first year), and the prevalence of dementia and pain or painful conditions may be as 
high as 82% in these settings. This means that approximately 800,000 people die in 
nursing homes and nearly 650,000 of these have dementia prior to demise. In addition, 
more than 50% of nursing home residents have pain and as many as 90% of those with 
cancer have pain. In 1989, the federal government extended hospice benefits to residents 
in nursing homes and in 1996 established diagnostic guidelines for admitting persons 
with dementia, but as shown above a large majority of hospice-eligible residents, 
especially those with CI, never benefit from its services. A major goal of this study is to 
document the impact of hospice on the terminally ill nursing home resident with CI who 
suffers significant pain and thus diminished quality of life. Its primary research question 
involves the identification of differences in pain assessment, pain management, and 
medication administration between two populations: nursing home resident with CI who 
received hospice services and residents with CI who did not. Instruments used to measure 
pain in persons with cognitive impairment are in the infancy stage of development. Most 
instruments rely on behavioral discomfort or pain cues. Determining the feasibility of 
using behavioral instruments among the more severely cognitively impaired is a 
secondary goal of this study.  
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CHAPTER 3.  HOSPICE IN U.S. NURSING HOMES: BENEFITS AND 
BARRIERS* 
INTRODUCTION 
 There is general consensus among experts that nursing home residents in the 
United States do not receive adequate pain management (Herr & Decker, 2004) or high-
quality palliative care, especially symptom management at the end of life (Duncan, 
Forbes-Thompson, & Bott, 2008; Hanson, Sengupta, & Slubicki, 2005).  Hospice can 
positively benefit end-of-life symptom management where about a fourth of adult deaths 
in the U.S. now occur (Ersek & Wilson, 2003; Hanson, Sengupta, et al., 2005). Almost 
50% of nursing home residents have dementia (Magaziner, et al., 2000) and the 
prevalence of pain or painful conditions is estimated to be between 49% and 83% among 
residents with dementia (Bjoro & Herr, 2008). This means that of the approximately 
800,000 residents in the U.S. who die in nursing homes, over 400,000 have dementia and 
650,000 have pain. Enrollment in hospice at the end of life in the nursing home is one 
way to improve care for these residents.  Currently, 2% of residents are enrolled in 
hospice upon admission (Parker-Oliver, Porock, Zweig, Rantz, & Petroski, 2003)  while 
6% (Miller, Mor, & Teno, 2003) of nursing home residents are enrolled in Hospice prior 
to death. Finding ways to improve hospice enrollment among nursing home residents, 
especially those with dementia and pain, remains a clear challenge.   
 
 In 1996, Medicare hospice services were extended to terminally ill older adults 
with severe cognitive impairments (Cherney, 2008). These new guidelines covered many 
nursing home residents who were not previously eligible for hospice. Countless older 
adults with severe cognitive impairment, especially those with Alzheimer’s disease, live 
and die in nursing homes which by 2003 was the fifth principal cause of death among 
individuals over the age of 65 in the U.S. (Mitchell, 2007). Hospice services can offer 
nursing home staff and families support while simultaneously helping manage pain, 
providing comfort, and easing the transition to death in older adults with cognitive 
impairment.  
 
 Since the approval in 1989 of a Medicare Hospice Benefit (MHB) (Centers for 
Medicare and Medicaid, 2008; Munn, et al., 2006), nursing homes have been able to offer 
a wide range of hospice services to dying residents (Figure 3-1). However, fewer than 
half of residents who are hospice eligible actually receive the benefit (Munn, et al., 2006). 
Miller and colleagues (2002), found that while 24% of nursing home residents were 
hospice eligible, only 6% of dying residents used the benefit, while Evans (2002) 
reported that only 1% of nursing home residents use the benefit, and fully 70% of all 
nursing homes have no resident enrolled in hospice (Keene & Thompson, 2008; Petrisek 
& Mor, 1999). These studies show an under use of hospice in nursing homes.  
 
 
*Reprinted with permission from Monroe, T & Carter, M. (2010) Hospice care in US 
nursing homes: benefits and barriers. European Journal of Palliative Care, 17(3),144-
149. 
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 Eligible for Part A of Medicare 
 Terminally ill with a life expectancy of 6 months or less 
 Physician and Advanced Practice Nursing (APN) services* 
 Medical care through the hospice Medical Director 
 Nursing Care 
 Case Management 
 Medical appliances and supplies 
 Medications related to the terminal illness and palliation of symptoms 
 Speech therapy 
 Short-term inpatient and respite care 
 Physical and occupational therapy 
 Dietary counseling 
 Homemaker and home health aide services 
 Continuous care 
 Counseling and social work services 
 Spiritual care 
 Volunteer participation 
 Bereavement services 
 Two 90-day certification periods† 
 An unlimited number of subsequent 60-day periods 
 
 
Figure 3-1  The Medicare Hospice Benefit 
* The first 90-day hospice certification must be approved by the beneficiary’s 
attending physician and the hospice medical director. The remaining 60-day 
periods require only 1 physician. 
† In 2004, the US Congress and Centers for Medicare and Medicaid Services 
developed new provisions in hospice care as a result of the Medicare Act of 2003: 
the definition of attending physician was changed to include nurse practitioners 
(NPs); however, nurse practitioners cannot certify a patient’s terminal illness as 
the physician. 
Adapted with permission from Centers for Medicare and Medicaid (2008) The Medicare 
hospice benefit. Retrieved November 24, 2008, from 
http://www.medicare.gov/publications/Pubs/pdf/02154.pdf 
 
 
 20 
 The purpose of this manuscript is to provide a broader understanding of hospice 
in nursing home settings by detailing the multiple benefits of its end-of-life care. Hospice 
care for nursing home residents with dementia and/pain is better when measured by 
documentation of assessment and administration of medications, documentation of 
receipt of alternative therapies, and documentation of fewer prescribed and administered 
inappropriate medications for use in the elderly. Hospice use is less costly to the total 
health care dollar because it decreases futile care at the end of life and reduces 
unnecessary hospitalizations. Barriers to hospice use in nursing homes are detailed, 
followed by a discussion of what nurses and others can do to increase hospice enrollment 
among nursing home residents. 
 
 
BENEFITS OF HOSPICE IN NURSING HOMES 
 
Better Pain and Symptom Management 
Nursing home residents receive several benefits from using hospice. Pain 
management has been a concern among nursing home residents for nearly 30 years 
(Ferrell, Ferrell, & Osterweil, 1990). More recently, investigators found that 86% of 
dying nursing home residents had pain and 53% of those had moderate to severe pain 
(Reynolds, et al., 2002). Hospice can provide several benefits for nursing home residents 
and pain management appears to be one advantage. One study showed that longer-stay (7 
days or more) nursing home residents in hospice had a greater (AOR = 5.4; 95% CI 1.3, 
21.7) likelihood of receiving an opioid and a greater (AOR = 2.7; 95% CI 0.9, 7.7; p = 
0.07) likelihood of receiving an opioid twice a day (Miller, et al., 2003). Other 
researchers found that residents enrolled in hospice were more likely to receive opioids 
for pain and two times more likely to have a documented pain assessment (Wu, et al., 
2003). Miller et al., (2002), reported the use of analgesic medication among hospice 
enrollees in nursing homes was 50% greater than non-hospice enrollees (OR  0.57; 95% 
CI 0.45, 0.7) Munn and colleagues (2006) compared nursing home residents enrolled in 
hospice and those who were not (N = 124). They found 85% of nursing home residents 
had moderate to severe pain compared to 52% of those enrolled in hospice (p < .05) and 
82% of hospice enrolled residents received pain medications compared to 50% of those 
not enrolled (p < .05). Nursing home residents enrolled in hospice experience a 93% 
(95% CI, 1.56 – 2.38) greater likelihood of having an attempt to manage documented 
pain (U. S. Department of Health and Human Services, 2000b). 
 
Researchers (2006) found that alternative pain management strategies such as ice 
packs and massage were more often used among hospice residents (26% vs. 6%, p = 
.004) and hospice residents were more likely to have assistance with eating (89% vs. 
63%, p = .01) and oral hygiene (96% vs. 78%, p = .03).  A meta-analysis of 19 
hospice/palliative care studies revealed that pain was mildly better managed by 
hospice/palliative care teams (OR = 0.38; 95% CI 0.23 – 0.64) and all other symptoms 
were moderately better managed by hospice/palliative care teams (OR = 0.51; 95% CI 
0.30 – 0.88) (Higginson, et al., 2003). Hospice is better at managing pain in nursing home 
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residents when pain management is measured by residents receiving opioids or other pain 
medications, or by the use of alternative therapies.  
 
Better overall pain and medication management are recognized benefits among 
residents using hospice. One study reported that hospice residents received fewer 
inappropriate medications as recommended by the American Medical Director’s 
Association (OR = 0.65; 95% CI 0.52-0.80, (Miller, et al., 2002). 
 
Pain management may be better among all residents when hospice is used in the 
facility, a phenomenon identified as the hospice effect. One possible cause is that nurses 
are reminded to assess and treat pain when they see hospice personnel in the building; 
their mere presence acts as a cue to other staff to manage the pain of non-hospice 
residents. Pain assessments were more likely in non-hospice individuals who resided in 
facilities where hospice was present (Wu, et al., 2003). Another example of the hospice 
effect is seen in cost savings to health care. Researchers found that non-hospice nursing 
home residents hospitalizations decrease as hospice enrollment increased (U. S. 
Department of Health and Human Services, 2000c).  
 
Residents enrolled in hospice (N = 1,982) were compared with those who were 
not (N = 6,392) (U. S. Department of Health and Human Services, 2000c). Detection of 
daily pain (as documented on the last MDS prior to death) was different among the 
groups. Residents enrolled in hospice with cancer and no dementia (n = 430), had daily 
pain (28.1%) and among those with cancer and dementia (n = 717), 16.0% experienced 
daily pain. Residents not enrolled in hospice with a diagnosis of cancer and no dementia 
(n = 1,529) had a pain detection rate of 16.8% and those not enrolled in hospice with a 
diagnosis of cancer and dementia (n = 2,293) had a pain detection rate of 8.9% (U. S. 
Department of Health and Human Services, 2000c). These same researchers found that 
among residents with dementia enrolled in hospice (n = 394) pain was detected in 11.4% 
compared to 5.0% among residents with dementia not enrolled in hospice, and for all 
“other” diagnoses enrolled in hospice (n = 441) pain was detected 17.5% of the time 
compared to a 7.8% pain detection rate for all “other” diagnoses non enrolled in hospice   
(U. S. Department of Health and Human Services, 2000c). This means that while hospice 
enrollees have better pain detection across the board, those residents diagnosed with 
cancer or cancer and dementia that are enrolled in hospice experience more frequent pain 
detection resulting in better quality of care. 
 
 
Financial Benefits 
 A final benefit may be evident in the costs savings to the health care system. 
Greater hospice enrollment may help ease the burden on the U.S. healthcare system, since 
health utilization costs decrease when residents are not constantly transported to and from 
the hospital and do not use acute care facilities (Susan L. Mitchell, et al., 2004). 
Investigators found almost half (43.7%) of nursing home residents compared to 31.5% (p 
= .001) with dementia (CPS score = 5 or 6) were hospitalized at least one time during the 
last 90 days of life (Susan L. Mitchell, et al., 2004) and decreasing just one hospital day 
per Medicare beneficiary can save the US health care system millions of dollars 
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(Kronman, Ash, Freund, Hanchate, & Emanuel, 2008). This means that residents with 
dementia and cognitive impairments are transported to hospitals more frequently (Teno, 
et al., 2004), when available hospice care can help relieve pain and provide support to the 
resident and family. Researchers found that more primary care visits in the year 
preceding death equated to fewer hospitalized days prior to death possibly attributed to 
increased opportunities to prevent medical complications and coordinating palliative 
home care (Kronman, et al., 2008). 
 
According to the U.S. Department of Health and Human Services (2000c), 
nursing home residents who use hospice are significantly less likely to be hospitalized in 
the last 30 days of life than those residents who do not (12.5% vs. 41.3%), in the last 90 
days (24.5% vs. 53%), and in the last 6 months (39.8% vs. 61.6%). More specifically, 
residents who use hospice save Medicare an average of $2309 per hospice user when 
compared to non-hospice decedents (p = .001) (Taylor, Ostermann, Van Houtven, 
Tulsky, & Steinhauser, 2007) and the U.S. Department of Health and Human Services 
(2000c) found the reduction in hospitalizations in the last 30 days translated into acute 
medical care savings of $2909 per resident.  
 
Investigators found that 25% of hospice users were enrolled for less than one 
week (Taylor, et al., 2007; U. S. Department of Health and Human Services, 2000b) and 
50% are enrolled less than 30 days (U. S. Department of Health and Human Services, 
2000c). Individuals with cancer save Medicare the most ($7000) while other primary 
conditions save $3500 noting that after 6 months of hospice, the savings to Medicare 
cease but do not increase over the non-hospice users (Taylor, et al., 2007). Residents who 
received information about palliative care and subsequent assistance enrolling in hospice 
had fewer acute care admissions (mean 0.28 vs. 0.49; p = .04) and experienced fewer 
hospitalized days (mean: 1.2 vs. 3.0; p = .03) (Casarett, et al., 2005). Thus, efforts to 
increase short-stay hospice offer a greater opportunity to save Medicare dollars over 
attempts to reduce long-stay hospice (Taylor, et al., 2007; U. S. Department of Health 
and Human Services, 2000b) and increasing the length of enrollment in 7 out of 10 
nursing home residents would greatly increase savings (Taylor, et al., 2007). Hospice 
could also help the financial picture of the nursing home in that the facility would be paid 
the daily rate rather than lose this payment during the resident’s hospitalization.  
 
 
BARRIERS TO HOSPICE USE 
 
Patient and Family Barriers 
In some situations, a family’s culture and religion may influence their decisions 
concerning hospice enrollment for their loved one. According to Jablonski and Wyatt 
(2005), Hispanic and African American families generally favor life-sustaining measures 
over palliative care, which may conflict with caregivers’ attempts to offer pain relief. 
Certain spiritual and religious traditions, such as a belief in God or higher power, may 
help individuals cope with the dying process and associated pain. The family may believe 
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that everything that can possibly be done must be done and life sustained at all costs even 
when this increases suffering of the resident and the family. 
 
Other resident and family barriers to hospice include patient preferences for life-
sustaining treatment, perhaps indicating a lack of understanding by the patient and family 
about the terminal nature of the diagnosis (Casarett, van Ness, O'Leary, & Fried, 2006), 
or perhaps a desire to not surrender to the disease. Casarett and colleagues (2004) found 
56% of patients and families were reluctant to accept the terminal nature of the diagnosis 
and most (91%) hospice-eligible older adults did not enroll until late in the course of a 6- 
month illness. Among residents enrolled in hospice, one third had been there less than 2 
weeks and one fifth less than 1 week (Dobbs, et al., 2006; Miller, et al., 2003). These 
studies suggest that in many circumstances, patients are not receiving the full benefit of 
hospice because of late enrollment. More education on hospice practices, and its 
provision earlier in the course of a patient’s likely terminal illness, would help address 
these issues. However, the likely reluctance of ‘giving up’ that is implied by engaging in 
hospice poses a significant barrier to enrollment.   
 
There are barriers to hospice enrollment that are specific to residents with 
dementia and/or severe cognitive impairment. One study found only 1 in every 10 
persons dying with dementia were enrolled in hospice (Sachs, Shega, & Cox-Hayley, 
2004). This low enrollment is likely the direct result of communication problems between 
residents and staff and 17% of nursing home nurses believe that hospice staff do not have 
the skills to care for residents with dementia (Tarzian & Hoffmann, 2006). This finding is 
interesting given that 59% of nursing home residents using hospice experience some 
cognitive impairment (Reynolds, et al., 2002). Mitchell, Kiely et al., (2004) reported that 
residents with cognitive impairments who are admitted to nursing homes had more 
functional disability, behavior problems, and tube feedings likely contributing to lower 
hospice enrollment. The authors also found that this cohort is often not recognized as 
terminally ill, with very infrequent (5.4%) referrals to hospice (Susan L. Mitchell, et al., 
2004). Communication difficulties between residents and nurses and difficulty 
recognizing deteriorations in health make enrolling residents with dementia difficult. 
Educating staff and family on the benefits of hospice use among residents with dementia 
could help to increase enrollment. Determining when a resident becomes terminal is not 
easy. 
 
A majority of hospice nurses (88%) and 45% of nursing home nurses believe that 
lack of knowledge about hospice on the part of residents and families is a barrier to 
hospice use (Tarzian & Hoffmann, 2006). Hospice enrollment increased after a brief 
structured interview between a clinician and nursing home residents and their families. 
The interview included information about the hospice philosophy and appropriateness for 
the resident. Within 30 days, 20% of the intervention group reported enrollment, versus 
1% for the nonintervention group (p <. 001) (Casarett, et al., 2005). The resident’s 
physician initiated hospice if appropriate after receiving a data sheet suggesting a 
potential fit for hospice. Another study revealed that 85% of patients and families decided 
to enroll in hospice after one conversation (Casarett, et al., 2004). One effective strategy 
to increase hospice enrollment that can be initiated by nurses or physicians appears to be 
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simple communication to residents and families about hospice and its role in end-of-life 
care.  
 
 
Nursing Home Staff Barriers 
Lack of knowledge about and familiarity with hospice and palliative care on the 
part of nursing home staff is one barrier to its full utilization in such settings. A study of 
nursing home and hospice nurses found that 92% of hospice nurses and 26% of nursing 
home nurses believed that a lack of knowledge about hospice on the part of the nursing 
home staff was a barrier to hospice enrollment (Tarzian & Hoffmann, 2006). Symptom 
relief is a major tenet of palliative care and overall symptom burden is higher among 
nursing homes than residential care or assisted living facilities (19.8% vs. 16.8%, p = < 
.001, (Hanson, et al., 2008). Jablonski and Wyatt (2005) explained that the problem of 
symptom relief in nursing homes may be exacerbated by the large numbers of unlicensed 
personnel lacking palliative education providing a majority of the care. In one study, 
nearly 20% of nursing homes did not provide formal training in end-of-life pain and 
symptom management and more than 50% of nursing home administrators believed that 
educational deficits were the single greatest obstacle to providing quality end-of-life care 
(Rice, Coleman, Fish, Levy, & Kutner, 2004). Unfortunately, the study by Hanson and 
colleagues (2008) found that nursing home staff had no recommendation or suggestion 
for improving symptom relief of pain (87%), dyspnea (89%), or cleanliness and oral 
intake (90%) at the end of life. All of these factors may create higher levels of family 
dissatisfaction with care, greater patient discomfort at the end of life, and increased 
chances that staff will not recognize a resident’s eligibility for hospice.  
 
 
Organizational and System Issues Barriers 
Another perhaps more determinant barrier is rooted in the core philosophical 
differences between traditional nursing home care which is on health maintenance, and 
established hospice practice which is palliative (Table 3-1). These differences are 
complicated by the documentation system used in nursing homes. The Minimum Data 
Set (MDS) focuses on restorative rather than palliative care (Evans, 2002; Tarzian & 
Hoffmann, 2006) and is required on each admission and quarterly thereafter. For 
example, the MDS focuses on health and functional indicators (Hoffman & Tarzain, 
2005) and does not promote symptom management such as pain control, dyspnea, end-of-
life issues, fatigue, or spiritual needs (Evans, 2002). An illustration of this policy conflict 
exists where the MDS mandates that evidence of a resident’s malnourishment be 
redressed; however, if the resident is dying decreased food intake may be part of the 
dying process and prolongation can actually increase suffering (Evans, 2002; Hoffman & 
Tarzain, 2005; Tarzian & Hoffmann, 2006).  Clearly, palliative care is not supported by 
the current MDS and improvements to the documentation system are needed.   
 
The resident plan of care potentially creates a significant barrier to enrollment. 
Parker-Oliver (2002) found among administrator’s and directors of nursing (DON’s) (N = 
60) confusion existed over the ultimate responsibility of the care of the resident with  
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Table 3-1  Differences in Care between Nursing Homes and Hospice* 
 
Care Characteristic Nursing Homes Hospice 
Curative or Restorative Care Yes No 
Palliative Care Sometimes Always 
Amount of Technical Care Work  
   (charting, taking vital signs,  
   hygienic care, etc.) 
High Low 
Amount of Relational Care Work  
   (spiritual or psychological  
   counseling, listening)  
Low High 
Care Recipient Resident Resident & Family 
Care Provided by Volunteers Seldom Often 
Grief Counseling Seldom Always 
*Adapted with permission from Parham, L. (2002) . Contrasts in care work: Hospice care 
in nursing homes (Doctoral Dissertation). Accessed July 17, 2008, from 
http://fs.aleph.fcla.edu/F/5BX3Y1FQMCI2V69V2XU9SVSU1QIYF21959T96J4L8FUB
6HX532-31842?func=full-set-set&set_number=002202&set_entry=000001&format=999 
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36% of respondents believed that the nursing home and hospice were responsible for the 
palliative plan of care, 18% identified hospice, and 6% did not know. Among this same 
cohort, only 38% believed they understood how hospice was reimbursed and 15% 
believed that hospice and nursing home boundaries were not clear (Parker-Oliver & 
Bickel, 2002). Another study of hospice nurses (N = 69) found that one third defined 
communication/miscommunication as one of the biggest problems working with hospice 
patients in nursing homes (Parker-Oliver, 2002). This means that lack of understanding 
about hospice and nursing home plans of care may lead to gaps in care, gaps in 
reimbursement, and potential liability. For example, the nursing home and hospice may 
establish two different wound care plans for the same patient. The resident lives in the 
nursing home making the nursing home liable, not the hospice, since this nursing home is 
responsible for the overall plan of care.  
 
Staffing shortages (Ersek & Wilson, 2003) and high employment turnover (Evans, 
2002) contribute significantly to low quality end-of-life care (Hanson, Sengupta, et al., 
2005; Rice, et al., 2004). Nursing home staff are generally the lowest paid in the industry 
(Ersek & Wilson, 2003) and this makes recruitment and retention very difficult. 
Investigators found turnover rates in Texas nursing homes were 133% for registered 
nurses, 108% for licensed vocational nurses, and 160% for certified nursing assistants 
(Kash, Castle, Naufal, & Hawes, 2006) and many nursing homes in Kansas also 
experience greater than 100% turnover for all staff (Clarkin, 2008).  Nursing home 
administrators also experience high turnover. Castle (2001) discovered 43% of nursing 
home administrators quit prior to completing one year of employment. Staffing shortages 
and high attrition make detailed assessments difficult, and most of the care is provided by 
licensed practical nurses with less education, especially in end-of-life care. This means 
discontinuity can occur between the hospice plan of care and the nursing home plan of 
care resulting from frequent staff turnover. 
 
Conflicts between hospice staff and nursing home staff also serve as a barrier to 
hospice use in nursing homes. Both hospices and nursing homes are regulated by the state 
and each has a different organizational structure and culture. Hospices provide “relational 
care” where nursing homes provide “routinized care” (Parham, 2002, p. 14). Relational 
care is more democratic with the resident and family having more choices and routinized 
care is very structured and bureaucracy driven (Parham, 2002). As a result, relationships 
between hospice and nursing homes staff can become strained, negatively impacting the 
resident’s care. Tarzian and Hoffman (2006) found that many nursing home staff 
believed that hospice staff were not familiar with nursing home policy and believe that 
most hospice staff rarely did anything that nursing home staff did not do. Another 
conflict was shared by nursing home nurses feeling like hospice nurses “know 
everything” and tend to “take-over” rather that work in a collaborative effort (Tarzian & 
Hoffmann, 2006). Parker-Oliver (2002) found hospice nurses have the following 
perceptions about nursing home nurses; 70% believe “hospice staff come and tell us what 
to do, yet we are here 24 hours a day”, 54% believe “hospice puts everyone on 
morphine”, and 53% believe “hospice just lets residents die”.  
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Financial concerns have been commonly identified as barriers to hospice use, 
particularly with regard to reimbursement and billing for specific services (Dobbs, et al., 
2006; Tarzian & Hoffmann, 2006). To cite but one example, Medicare’s Skilled Nursing 
Benefit will pay for room and board, whereas Medicare’s Hospice Benefit will not. This 
means that residents using the Medicare hospice benefit must find other resources to pay 
for room and board including out of pocket, private insurance or Medicaid resulting in a 
complicated and potentially lower reimbursement to the nursing home (Jablonski & 
Wyatt, 2005). A second issue concerns reimbursement methods. Hospice agencies’ 
reimbursement to nursing homes tends to operate more slowly than government 
healthcare agencies like Medicare and Medicaid (Evans, 2002). For example, if a resident 
is Medicaid eligible, Medicaid will pay the hospice 95% or more of the state’s daily 
nursing home rate, and then the hospice will reimburse the nursing home for room and 
board complicating payment to the nursing home (Parham, 2002). Another 
reimbursement concern is that nursing homes receive higher payment for rehabilitative 
rather than palliative care, therefore revenue will be higher in nursing homes not using 
hospice (Jablonski & Wyatt, 2005).  
 
 
Other Barriers 
Difficulty in determining the 6-month window to death, required by Medicare, 
may serve as another barrier to hospice enrollment (Lorenz, Shugarman, & Lynn, 2006). 
Many physicians’ are uncomfortable in estimating demise among residents, especially 
those with dementia (Evans, 2002; Mitchell, 2007), congestive heart failure and chronic 
obstructive pulmonary disease (Lorenz, et al., 2006) compared to those with cancer who 
typically follow a predictable trajectory (Lorenz, et al., 2006). For example, one 
instrument used to establish hospice eligibility for persons with dementia is the 
Functional Assessment Staging (FAST) scale (Reisberg, 1988). However 40% of 
residents in one study could not be evaluated with the FAST scale (Figure 3-2) because 
their disease progression did not match FAST scale progression (Luchins, et al., 1997). 
Episodic periods of deterioration and recovery are common in nursing home residents, 
and this makes determining when the resident is in the final 6 months of life difficult. 
This means that admission into hospice only need be determined by prognosis and 
hospice can be renewed if they do not die within six months as long as the resident meets 
the conditions for enrollment. 
 
 
WHAT NURSES AND OTHER CARE PROVIDERS CAN DO TO INCREASE 
HOSPICE ENROLLMENT 
 Education and awareness can have positive results on hospice enrollment. Hanson 
et al., (2005) reported an increase in rates of hospice enrollment from 4.0% prior to an 
educational intervention to 6.8% post-intervention (4.0%-6.8%, p = 0.01). Staff reported 
an increase from 66% to 85% in their confidence to provide palliative care while 
concurrently increasing hospice enrollment from 35 to 59 residents among the seven 
nursing homes studied after participating in a 1-day educational program on palliative 
care. Hospice access is also more likely when a contract exists between the nursing home  
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Eligibility criteria for hospice using the FAST scale (must have both) 
1. Functional Assessment Staging (FAST) level of stage 7c or beyond and evidence all 
components of stages 6a-7c 
2. The individual must have one of the following associated medical conditions within the 
previous year* 
FAST Stage 1: No objective of subjective difficulties 
FAST Stage 2: Subjective reports of forgetting 
FAST Stage 3: Decreased job functioning evident to coworkers. Difficulty traveling to new 
locations 
FAST Stage 4: Decreased ability performing complex tasks (e.g., planning dinner for guests, 
handling finances) 
FAST Stage 5: Requires assistance to choose proper clothes for day, season, or occasion 
FAST Stage 6a: Cannot dress without assistance occasionally or more frequently 
FAST Stage 6b: Cannot bathe without assistance occasionally or more frequently 
FAST Stage 6c: Cannot toilet without assistance occasionally or more frequently 
FAST Stage 6d: Incontinent of urine occasionally or frequently 
FAST Stage 6e: Incontinent of bowel occasionally or frequently 
FAST Stage 7a: Speech limited to fewer than 6 intelligible words during an average day† 
FAST Stage 7b: Speech limited to a single intelligible word during an average day 
FAST Stage 7c: Unable to ambulate independently 
FAST Stage 7d: Cannot sit up independently 
FAST Stage 7e: Cannot smile 
FAST Stage 7f: Cannot hold head up independently 
 
 
Figure 3-2. Determining Hospice Eligibility for Individuals with Dementia 
*Associated Medical Conditions (must have one within previous year): Aspiration 
pneumonia, pyelonephritis or other upper urinary tract infection, septicemia, decubitis 
ulcer (multiple, stage 3-4), recurrent fever after treatment with antibiotics, eating 
problems such that fluid or food intake is insufficient to sustain life (or, if tube fed, 
weight loss > 10% over prior 6 months or serum albumin <2.5 g/dl). 
†Stage 7a: In some geographical areas of the country, individuals with a FAST stage of 
7a are eligible for hospice (Cherney, 2008). 
Source: Adapted with permission from Mitchell, S. L. (2007). A 93-year-old-man with 
advanced dementia and eating problems. Journal of the American Medical Association, 
298(21), 2257-2536. 
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and hospice (Rice, et al., 2004). Nurses and health care providers who are themselves 
better educated on the benefits of hospice can provide education and awareness to 
residents, their families, and the community positively improving hospice enrollment. 
Many of these opportunities are currently available on-line (Table 3-2). 
 
 Braun and Zir (2005) developed the Appropriateness Care of Residents in 
Nursing Homes (ACORN) to teach nursing home workers about end-of-life care. 
Registered nurses and certified nursing assistants (CNAs) participated in the training. 
ACORN training consisted of 8 interactive one-hour sessions located in 10 nursing 
homes. Topics included: pain assessment and management, symptom management, 
advanced directives, cultural issues and dying, and grief support. Pre and post-
intervention knowledge was significant (p = .01) among CNAs in all five categories 
measured: comfort, knowledge of death and dying, grieving, facility deals with dying, 
and pain management. However nurses reported only one area of significant (p = .01) 
knowledge growth, facility deals with dying. Evidently, ACORN is better at helping 
paraprofessionals increase their knowledge of end-of-life care. Residents, families, and 
staff may benefit from an educational intervention such as ACORN. Nursing assistants 
spend considerable time with residents and educational interventions that target these 
individuals may well serve residents, families, and facilities. Paying for ACORN or other 
educational training presents financial considerations for nursing home administrators.  
 
 
SUMMARY 
To summarize, there are many benefits to hospice use in nursing homes. First pain 
and non-analgesic medication management is better among hospice enrollees possibly 
attributed to the increased numbers of professionals participating in care including, 
nurses, physicians, clergy, and social workers that have training in palliative care. Next, 
greater symptom recognition and management occurs among residents enrolled in 
hospice and this dually contributes to increased comfort for residents and better attitudes 
from the resident and family favoring hospice services. A better relationship between 
hospice personnel and residents and their families helps each to become more 
comfortable with the terminal prognosis. Hospice can save significant health-care dollars 
by reducing unnecessary expenditures associated with unnecessary end-of-life treatments 
and frequent transfers from nursing homes to hospitals to expire.  
 
Unfortunately, each of these benefits may not be realized because of any one or 
combination of barriers to hospice enrollment. Often there are barriers associated with 
family and resident knowledge deficits about hospice. These become evident when deep 
rooted cultural beliefs conflict with hospice philosophy such as a preference for life-
sustaining treatments. Inability of staff to recognize and manage end-of-life symptoms, 
especially among residents with dementia hinder early hospice enrollment. Staffing 
shortages and high turnover in nursing homes can directly affect hospice enrollment, 
especially when attempting to keep staff trained on end-of-life care. Finally, 
reimbursement issues and cultural clashes may hinder enrollment. Organizational clashes 
exist between restorative nursing home guidelines and palliative hospice principles. 
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Table 3-2  On-line End-of-life Educational Resources for Nurses 
 
Resource Description Source for On-line Information 
ELNEC End-of-Life Nursing Education 
Consortium offers a series of 
modules designed to “train the 
trainer” about end-of-life 
issues 
 
www.aacn.nche.edu/elnec/ 
PERT Palliative Care Educational 
Resource Team provides 
education to licensed and 
unlicensed staff, including 
decision-making skills and 
end-of-life care for residents 
with dementia 
 
www.swedishmedical.org/PERT.htm
 
TNEEL Toolkit for Nurturing 
Excellence at End-of-Life 
Transition Program is based on 
the American Association of 
Colleges of Nursing’s 
competencies in palliative 
education 
 
www.tneel.uic.edu 
HPNA The Hospice and Palliative 
Nurses Association provides a 
wealth of information, 
including position statements 
and assistance with standards 
of care 
 
www.hpna.org 
Wisconsin Palliative Care Program at the 
Medical College of Wisconsin 
www.mcw.edu/pallmed 
Rhode Island Rhode Island Partnership to 
Improve End-of-Life care: 
“Train the Trainer” educational 
curriculum and “Continuous 
Quality Improvement Project 
in Pain Management” 
 
www.chcr.brown.edu/commstate 
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IMPLICATIONS 
Much of the literature on increasing hospice enrollment in nursing homes is 
focused on educational interventions. Many of the barriers identified warrant further 
investigation beyond educational initiatives. Exploring cultural backgrounds or speaking 
with a pastor may be the catalyst to hospice enrollment. Likewise, exploring potential 
areas of liability for hospice in nursing homes are needed. In addition, many authors seem 
to focus on the idea of hospice in the “home” setting and while the nursing home does 
become a residents “home”, hospice brings different concerns into this setting. 
 
Conflicts between nursing home and hospice staff may require a proactive 
administrative lead. Techniques that increase individual empowerment could reduce this 
friction. This means asking nursing home nurses to help determine which residents may 
be hospice eligible and then reinforcing how hospice benefits the resident first, but may 
inadvertently offer the nurse much needed assistance with care. Administrators who 
invite hospices to bring “open houses” into the facility see the benefits of breaking down 
these traditional organizational barriers creating a “win-win” situation for everyone. 
However, careful consideration for hospice and nursing home policy and procedure are 
needed. Administrators and staff who understand the rules and regulations of hospice and 
long-term-care are better prepared to work together. This means that the continuity of 
care receives less interruptions and the risk for liability is decreased. 
 
More system-wide barriers may require stakeholders creating key policy 
initiatives at the state and federal level. The MDS 3.0 will be available in 2009 and many 
of the concerns related to lack of palliative care might be better addressed. Initiatives 
creating transparent and sound reimbursement options between hospice and nursing 
homes should be at the forefront of policy development. Nursing homes may continue to 
seek higher paid interventions until equal reimbursement occurs for hospice, palliative, 
and restorative care.  
 
Identifying individuals who are terminal and expected to live less than 6 months 
has been identified as a barrier to enrollment. This practice is the result of the Medicare 
Hospice Benefit (MHB) requiring a physician to certify that a resident has less than 6 
months to live. However, this should not be a significant barrier to enrollment. Residents 
who meet recommended guidelines should be offered hospice services. Furthermore, 
residents can be recertified for an indefinite number of recertification periods. A resident 
and family can benefit from hospice for well more than 6 months. An educated family in 
conjunction with a prudent physician and nurse practitioner can be a strong force for 
initiating hospice services. 
 
In conclusion, hospice has been helping individuals in the transition from life to 
death with as little pain and discomfort as possible for nearly 30 years, but currently more 
nursing home residents could be receiving the benefits of hospice than is now the case. 
Nurses and healthcare professionals working in long-term facilities should be encouraged 
to make a commitment to overcoming the barriers identified here to help increase hospice 
enrollment and provide the best possible care for residents approaching the end of life. 
Participating in on-line courses combined with on the job training is a first and important 
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step to better prepare nursing home staff to manage terminal residents. However, much 
more needs to be done at the system level through state and federal policy change.  
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CHAPTER 4.  METHODS 
PURPOSE 
The purpose of this study was to identify the differences in pain medication 
administration between two different groups of deceased subjects, nursing home residents 
with malignant cancer and dementia with and without hospice services. 
 
 
DESIGN AND SETTING 
 This study was a retrospective study of pain medication administration in nursing 
home residents who died with cancer and dementia and who received hospice services 
compared to residents who did not receive hospice services. The last 14 days of life were 
examined for this study.  
 
 Nursing homes throughout western Tennessee were recruited. Ten nursing homes 
agreed to participate. One nursing home yielded no subjects leaving a final sample 
consisting of nine nursing homes, seven non-profit and two for-profit. 
 
 This cross-sectional study explored the frequency, types, and amounts of pain 
medication administered, while simultaneously a case-control design examined the 
differences between a group of residents with hospice services and a group of residents 
without hospice services for the relationships among pain, cancer, and dementia. 
 
 
SPECIFIC AIMS AND HYPOTHESES 
The primary aims of this study were (1) to determine the differences in 
administered pain medications for cognitively impaired residents who died from cancer 
while receiving hospice services as compared with those not receiving hospice services 
and (2) to determine if discomfort related pain behaviors among nursing home residents 
with cancer and dementia decrease with increasing cognitive impairment.  
 
 
Specific Aim One 
 Specific Aim One was to determine the differences in administered pain 
medications for cognitively impaired residents who died from cancer while receiving 
hospice services as compared with those not receiving hospice services. The following 
eight hypotheses were associated with this aim.  
 
 Hypothesis 1. Residents who received hospice services would receive more 
scheduled narcotic analgesic than residents who did not receive hospice 
services. 
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 Hypothesis 2. Residents who received hospice services would receive greater 
total equivalent dose units (EDU’s) of narcotic analgesic than residents who 
did not receive hospice services.   
 Hypothesis 3. Residents who received hospice services would receive greater 
total dose number of non-narcotic analgesics (TDNN) than residents who did 
not receive hospice services.   
 Hypothesis 4. Residents who received hospice services would receive more 
PRN narcotic analgesic than residents who did not receive hospice services. 
 Hypothesis 5. Residents who received hospice services would receive more 
scheduled non-narcotic analgesic than residents who did not receive hospice 
services. 
 Hypothesis 6. Residents who received hospice services would receive more 
PRN non-narcotic analgesic than residents who did not receive hospice 
services.   
 Hypothesis 7. Residents who received hospice services would have different 
cognitive performance scores (CPS) than residents who did not receive 
hospice services.  
 Hypothesis 8. Residents who received hospice services would receive greater 
total dose numbers of drug potentiators (TDNP) than would residents who did 
not receive hospice services.  
 
Specific Aim Two 
Specific Aim two was to determine if discomfort related pain behaviors among 
nursing home residents with cancer and dementia decrease with increasing cognitive 
impairment. The following hypothesis is associated with this aim. 
 
 Hypothesis 9. Discomfort related pain behaviors among all residents will be 
decreased with increasing cognitive impairment. 
 
 
HUMAN SUBJECTS CONSIDERATION 
 Approval was obtained from the University of Tennessee Health Science Center 
Review Board for the dates needed for data collection. Clarification and revision required 
by the IRB was done. The study was approved and given exempt status (Appendix A) 
and a revision for recruitment was approved (Appendix B). 
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METHODS 
 The sample was drawn from nursing home residents with malignant cancer and 
dementia in nine nursing homes in western Tennessee.  The facilities were a mix of for 
profit (n = 7) and nonprofit (n = 2) with a size range of 68 to 180 beds.  
 
 Inclusion criteria were residents who resided and died in a nursing home between 
January 1, 2003 and July 1, 2009 with malignant cancer and dementia. Initial subject 
recruitment began by using Vista KEANE MDS® software in each nursing home (Keane 
Care Inc. Redmond WA). Prospective subjects were located using the following 
methodology: First, 10 malignant cancer codes were used to search “client by diagnosis”. 
“Client by diagnosis” is a default option in the software used to locate nursing home 
residents with specific traits. The cancer diagnoses as described in chapter 5 were 
obtained from the Centers for Disease Control (CDC) top 10 cancers of the overall 
population for all races and genders in 2004 (Centers for Disease Control, 2007). No 
subjects were located who had non-Hodgkin’s lymphoma but the other nine are 
represented in the sample. 
 
 Second, each medical record was retrieved to determine a positive diagnosis of 
Alzheimer’s disease, Lewy body dementia, vascular dementia, or mixed. Third, a CPS 
score was calculated from their admission MDS. The CPS was calculated from the first 
MDS because CPS scores may decline over time but were not likely to improve. The CPS 
is calculated using a specific algorithm and scoring grid using specific MDS items. 
Fourth, a DBS score was calculated from the most recent MDS before death realizing the 
most recent MDS may have been in the previous 90 days. Lastly, a diagnosis of 
malignant cancer and cause of death were confirmed in the medical record. This 
methodology was thought to be the best way to capture active cancer pain among 
individuals with dementia in a retrospective study.  
 
 Exclusion criteria were inability to determine the cause of death, and incomplete 
or missing medical records. A total of 55 subjects meeting eligibility were located and 
met inclusion criteria.   
 
 
Pain Medication Administration 
 A Medical Chart Review Form (MCRF) was created for data collection 
(Appendix C). The primary diagnosis was noted. Opioid containing medications were 
documented, both scheduled and PRN doses and amounts were recorded over the last 14 
days of life. Non-analgesic medications (potentiators) were documented and counted over 
the last 14 days of life. The dose amount for narcotic medications was entered into the 
MCRF form. Opioids were converted to equivalent dose units (EDU’s) for analysis using 
the formula specified by the Equianalgesic Opioid Conversion rations for Patients 
Previously Receiving Other Opioids (Arkansas Medicaid) on-line calculator (Arkansas 
Medicaid, 2007). This calculator provides an EDU conversion factor for converting 
narcotic dosages to EDU’s. For example, a resident received 30 total mg of Morphine, 40 
mg of Hydrocodone, and 125 mcg of Fentanyl over the last two weeks of life. Each of 
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these has an EDU equivalency. Thirty mg of Morphine equals 1.13 EDU’s, 40 mg of 
hydrocodone equals  1.33 EDU’s , and 125 mcg of Fentanyl equals 15.0 EDU’s for a 
total of 17.43 EDU’s during the last two weeks of life.  
 
 
Demographics/Sample Characteristics 
Demographic information included age, gender, type of cancer, facility, and 
ethnicity (African-American, Caucasian). The hospice group was compared to the non-
hospice group for equivalency using the Spearman’s Rank Correlation procedure and the 
Mann Whitney U statistic. 
 
 The primary aims of this study were (1) to determine the differences in 
administered pain medications for cognitively impaired residents who died from cancer 
while receiving hospice services as compared with those not receiving hospice services 
and (2) to determine if discomfort related pain behaviors among nursing home residents 
with cancer and dementia decrease with increasing cognitive impairment.  
 
 
Specific Aim One 
 Specific Aim One was to determine the differences in administered pain 
medications for cognitively impaired residents who died from cancer while receiving 
hospice services as compared with those not receiving hospice services. The following 
eight hypotheses were associated with this aim.  
 
 Hypothesis 1. Residents who received hospice services would receive more 
scheduled narcotic analgesic than residents who did not receive hospice 
services. 
 Hypothesis 2. Residents who received hospice services would receive greater 
total equivalent dose units (EDU’s) of narcotic analgesic than residents who 
did not receive hospice services.   
 Hypothesis 3. Residents who received hospice services would receive greater 
total dose number of non-narcotic analgesics (TDNN) than residents who did 
not receive hospice services.   
 Hypothesis 4. Residents who received hospice services would receive more 
PRN narcotic analgesic than residents who did not receive hospice services. 
 Hypothesis 5. Residents who received hospice services would receive more 
scheduled non-narcotic analgesic than residents who did not receive hospice 
services. 
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 Hypothesis 6. Residents who received hospice services would receive more 
PRN non-narcotic analgesic than residents who did not receive hospice 
services.   
 Hypothesis 7. Residents who received hospice services would have different 
cognitive performance scores (CPS) than residents who did not receive 
hospice services.  
 Hypothesis 8. Residents who received hospice services would receive greater 
total dose numbers of drug potentiators (TDNP) than would residents who did 
not receive hospice services.  
 
Specific Aim Two 
Specific Aim Two was to determine if discomfort related pain behaviors among 
nursing home residents with cancer and dementia decrease with increasing cognitive 
impairment. The following hypothesis is associated with this aim. 
 
 Hypothesis 9. Discomfort related pain behaviors among all residents will be 
decreased with increasing cognitive impairment. 
 
 
Testing the Hypotheses 
In order to test the hypotheses, data were collected in the following manner: 
 
 All scheduled opioids and dose given were entered into the MCRF, if no 
opioid was administered then a “0” was entered for that day.  
 All PRN opioids and dose given were entered into the data collection, if no 
PRN opioid was administered then a “0” was entered for that day.  
 All scheduled non-narcotic analgesics types and dose given were entered into 
the MCRF, if no non-narcotic analgesic was administered then a “0” was 
entered for that day.  
 All PRN non-narcotic analgesic types and dose given were entered into the 
MCRF; if no non-narcotic analgesic was administered then a “0” was entered 
for that day. 
 All scheduled potentiators, types and dose given were entered into the MCRF, 
if none were administered then a “0” was entered for that day. 
 All PRN potentiators, types and dose given were entered into the MCRF; if 
none were administered then a “0” was entered into the form. 
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 CPS and DBS scores were calculated on each subject using the established 
scoring grid for each instrument. 
 
Mann Whitney U procedures were conducted on Hospice / Non Hospice and 
continuous variables. Bivariate correlations were conducted and reported on hospice 
enrollment and DBS scores. The Kruskal-Wallis procedure was conducted to answer the 
final hypothesis. Alpha was set at 0.05. Beta was set at 0.20 (power of 80). 
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CHAPTER 5.  RESULTS 
SAMPLE CHARACTERISTICS AND DEMOGRAPHIC DATA 
 Sociodemographic characteristics are located in Table 5-1. Forty-five percent 
were male, 29% were African American, and 45% were enrolled in hospice. The mean 
age of the sample was 86 (SD 7.84). Hospice enrollees are further described in Table 5-2. 
Frequency and percentages of cancer types are listed in Table 5-3. Greater than 50% of 
decedents had either colon/rectal or breast cancer.  
 
Table 5-4 shows the results of hospice enrollment correlated with categorical 
demographic and pain variables. Gender and race were included in the table for 
completeness. 
 
Table 5-5 shows the results of The Mann Whitney U Statistic between hospice 
enrollment and continuous study variables. Age was included in the analysis for 
completeness.  
 
Hypothesis 1 was, “Residents who received hospice services would receive more 
scheduled narcotic analgesic than residents who did not receive hospice services.” This 
hypothesis was tested using The Spearman’s correlation procedure (Table 5-4) and an 
Odds Ratio. This hypothesis was accepted. There is a significantly greater likelihood of 
being prescribed a scheduled narcotic analgesic (OR 5.5; 95% CI 1.8 – 18.8) when 
enrolled in hospice. 
 
 Hypothesis 2 was, “Residents who received hospice services will have different 
pain management measured by greater total EDU’s during the last two weeks of life? 
This hypothesis was tested using the Mann Whitney U statistic. The results are found in 
Table 5 with descriptive statistics in Table 5-6. This hypothesis was accepted. Total 
EDU’s were significantly greater among hospice enrollees (U 226.5, p <.05).  
 
 Hypothesis 3 was, “Residents who received hospice services will have different 
pain management evidenced through receiving more TDNN during the last two weeks of 
life?” This hypothesis was tested using the Mann Whitney U statistic (Table 5-5). This 
hypothesis was rejected. 
 
 Hypothesis 4 was, “Residents who received hospice services will have different 
pain management evidenced through being prescribed more of PRN narcotics?” This 
hypothesis was tested using the Spearman’s correlation procedure (Table 5-4) and an 
Odds Ratio. This hypothesis was accepted. There is a significantly greater likelihood of 
being prescribed a PRN narcotic analgesic (OR 3.6; 95% CI 1.2-11.3) when enrolled in 
hospice. However, individuals with higher cognitive levels were more likely (OR 3.67; 
95% CI 1.19-11.26) to be prescribed a PRN narcotic. Lower cognitive levels were 
defined as individuals with a CPS score of 4, 5, or 6 compared to higher cognitive levels 
with a CPS score of 1, 2, and 3. 
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Table 5-1  Sociodemographics of Study Sample (N = 55) 
 
Characteristic n (%) 
Gender  
Male 25 (45) 
Female 30 (54) 
Race / Ethnicity  
White 39 (71) 
Black 16 (29) 
Mean Age (Standard Deviation): Hospice patients, 86 (8.81); Non-hospice patients 88 
(6.71) 
 
 
 
 
Table 5-2  Characteristics of Hospice Decedents (N = 25) 
 
Characteristic n (%) 
Hospice patients 25 (45) 
Gender  
Male hospice patients 11 (20) 
Female hospice patients 14 (25) 
Race / Ethnicity  
White hospice patients 16 (29) 
Black hospice patients 6 (11) 
N = total number of hospice decedents; n = number in each characteristic subgroup 
 
 
 
 
Table 5-3  Frequency and Percentage of Cancer Types (N = 55) 
 
Cancer Type n (%) 
Colon / Rectal 15 (27.3) 
Female breast 14 (25.5)  
Prostate 9 (16.4)  
Lung/Bronchiole 6 (10.9)  
Uterine 3  (5.5)  
Melanoma of skin 2  (3.6)  
Ovarian 2  (3.6)  
Kidney/Renal 2  (3.6)  
Bladder 1  (1.8)  
N = total number of hospice decedents; n = number in each characteristic subgroup 
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Table 5-4  Correlations with Hospice Enrollment 
 
 Gender Race 
Scheduled 
Narcotics 
PRN 
Narcotics 
Scheduled 
Non-
narcotics 
PRN 
Non-
narcotics 
Spearman’s - rho -.027 -.102 .393    .312 .257 .137 
Sig (1-tailed)   .423  .229   .001*   .010† .137 .160 
* p < .01; †p < .05 
PRN = as the situation demands 
 
 
 
 
Table 5-5  Hospice Enrollment and Continuous Study Variables 
 
 Age  TDNN*  TDNP†  CPS‡ EDU§ 
Mann Whitney U 321.5 339.0 292.5 183.5 226.5 
Z -.671 -.437 -1.217 -3.122 -2.533 
Asymp. Sig (1-tailed)  .251  .331    .112      .0011     .0051 
1 p < .01 
TDNN = total dose number of narcotics; TDNP = total dose number of potentiators;  
CPS = cognitive performance scale; EDU = Equianalgesic dose units (of opioid) 
*TDNN were calculated by counting all dose number of narcotic during the last 2 weeks 
of life.  
†TDNP were calculated by counting all dose number of potentiators; i.e., 
benzodiazipines, sedatives, hypnotics, during the last 2 weeks of life.  
‡CPS scores were calculated from the admission Minimum Data Set using the 
instrument algorithm.  
§EDU’s were calculated over the last 2 weeks of life and placed directly into the on-line 
calculator and converted to EDU amounts. 
 
 
 
 
Table 5-6  Descriptive Sample Statistic of Hospice Enrollment and Mean Rank EDU  
 
Hospice  n Mean Rank EDUs Sum of Ranks 
Yes 25 33.94 848.50 
 No 30 23.051 691.50 
n = number in each group; EDU = Equianalgesic dose units (of opioid) 
1p <.01 (1 tailed) 
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 Hypothesis 5 was, “Residents who received hospice services will have different 
pain management evidenced by being prescribed more scheduled non-narcotic 
analgesic?” This hypothesis was tested using The Mann Whitney U statistic (Table 5-5). 
This hypothesis was rejected. 
 
 Hypothesis 6 was, “Residents who received hospice services will have different 
pain management evidenced by being prescribed more an as needed (PRN) non-narcotic 
analgesic?” This hypothesis was tested using The Mann Whitney U statistic (Table 5-5). 
This hypothesis was rejected. 
 
 Hypothesis 7 was, “There are no differences between cognitive abilities between 
residents who received hospice services and those who did not. This hypothesis was 
tested using The Mann-Whitney U Statistic (Table 5-5). This hypothesis was rejected. 
Descriptive statistics for this hypothesis are found in Table 6. Hospice enrollment 
decreased as cognitive impairment increased (U 220.0, p < .01) with no individuals with 
a CPS score of 6 (very severe impairment) enrolled in hospice. Descriptive statistics for 
this hypothesis are found in Table 5-7. 
 
 Hypothesis 8 was, “Residents who received hospice services will have different 
pain management evidenced by receiving more TDNP during the last two weeks of life?” 
This hypothesis was tested using the Mann Whitney U Statistic (Table 5-5). This 
hypothesis was rejected. 
 
Hypothesis 9 was, “Discomfort related pain behaviors among all residents will be 
decreased with increasing cognitive impairment.” This hypothesis was accepted. 
Decedents with lower cognitive levels were more likely (OR 4.9; 95% CI 1.6-15.6) to 
have a DBS score of zero. Lower cognitive levels were defined as individuals with a CPS 
score of 4, 5, or 6 compared to higher cognitive levels with a CPS score of 1, 2, and 3. 
Descriptive statistics for this hypothesis are found in Table 5-8. 
 
An expert in pain, Perry Fine (personal communication, September, 21, 2009) 
was asked to rate the cancer types as those likely to be painful to further explore the 
phenomenon that no person with very severe cognitive impairment was enrolled in 
hospice and that 40% of the subjects did not receive any narcotic analgesic at the end of 
life and of these 31% were not enrolled in hospice while 9% were This resulted in a 
dichotomous variable of cancer with “predictably painful” tumors that metastasize to the 
bone (breast, lung, prostate, and renal) and those that do not (colon/rectal, bladder, 
melanoma of the skin, ovarian, and uterine). Using Crosstabs in SPSS 16.0, this analysis 
resulted in 9 individuals with predictably painful metastatic cancer who were very 
severely cognitively impaired receiving no narcotic analgesic during the last two weeks 
of life. Of note is that 29 of the 42 subjects (70%) who did not receive any narcotic 
analgesic at the end of life had predictably painful metastatic cancer.   
 
In summary, this study enrolled approximately 50% of each gender. One out of 
every three individuals was African American and the average age was 87. Nearly half of 
the individuals were enrolled in hospice and 50% of all subjects had breast or colon/rectal 
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Table 5-7  Descriptive Sample Statistics of CPS Groups 
 
CPS* score N (hospice = n) Mean EDU’s (SD) 
1 7(4) 10.13 (11.14) 
2 7(5) 21.83 (12.40) 
3 11(8) 12.08 (12.40) 
4 10(2) 10.77 (17.05) 
5 8(5)  2.36 (6.13) 
6 12(0)† 4.0 (7.45) 
N = total number in each CPS subgroup, n = total number of hospice enrollees in each 
subgroup 
*CPS is scored from 1 = borderline cognitively intact to 6 = very severely cognitively 
impaired. 
† No individual with a CPS score of 6 was enrolled in hospice. 
 
 
 
 
Table 5-8  CPS and DBS Group Comparisons 
 
CPS Mean DBS (SD) 
1 (n = 7) 4.43(5.02) 
2 (n = 7) 4.43(7.34) 
3 (n = 11) 9.09 (7.46) 
4 (n = 10) 7.70 (16.31) 
5 (n = 8) 6.12 (11.52) 
6 (n = 12) 1.92 (3.59)* 
N = total number in each CPS group, SD = standard deviation 
*Decedents with lower cognitive levels (4,5,6 vs. 1,2,3) were more likely [OR 4.9; 95% 
CI 1.6-15.6] to have a DBS score of zero. 
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cancer. The group sizes and data distribution were appropriate for nonparametric 
procedures. The Spearman’s correlations and Odds ratios showed strong correlations 
between hospice enrollees and being prescribed a scheduled narcotic and higher cognitive 
levels and being prescribed a PRN narcotic. The Mann-Whitney U Statistic showed a 
significant relationship between hospice enrollees, CPS score and total EDU’s indicating 
that as cognitive impairment increases both hospice enrollment and total dose of opioid 
analgesic decrease. No individual with very severe cognitive impairment was enrolled in 
hospice services. 
 
 
DISCUSSION 
 This study adds to and extends the current literature on pain management in the 
nursing home. This study shows that untreated pain continues to be a serious problem 
among nursing home residents with dementia. The literature is extended by showing that 
nearly half of the subjects enrolled received no narcotic pain medication in the presence 
of likely painful bone metastasis.  
 
 These findings also suggest that very severely cognitively impaired individuals 
are not enrolled in hospice. None of the subjects with a CPS score of 6 were enrolled in 
hospice. The relationship between hospice enrollment and CPS scores is telling. CPS 
scores of 4, 5, and 6 have been shown to correlate with an MMSE score of < 10 and CPS 
scores of 5 and 6 correlate with an MMSE score of < 5 (Hartmaier, et al., 1995; Morris, et 
al., 1994) (Morris, Fries, Mehr, et al 1994; Hartmaier, Sloane, Guess, Koch, Mitchell, 
Phillips, 1995) (Hartmaier, et al., 1995; Morris, et al., 1994). This suggests that the most 
severely cognitively impaired are not being enrolled in hospice and that current methods 
used to determine hospice enrollment among persons with malignant cancer and very 
severe cognitive impairment do not work among nursing homes in western Tennessee. A 
secondary reason for decreased hospice enrollment appears to be blunted pain related 
behaviors. Individuals with CPS scores of 6 had the lowest DBS scores and this study 
showed that DBS scores significantly decrease with increasing cognitive impairment. 
Hospice enrollment might have increased the use of narcotic analgesia at the end of live 
for these residents. 
 
 Nursing home residents enrolled in hospice were more likely to be prescribed a 
narcotic and thus received larger quantity of narcotic analgesic during the last two weeks 
of life. Introducing this paradigm into practice among nurse practitioners and physicians 
who provide primary care could help reduce the amount of untreated pain in the nursing 
home. This means that prescribing scheduled medications (narcotic or non-narcotic) for 
various painful co-morbidities appears to be one way to reduce the possibility of being 
untreated for pain. Among the severely cognitively impaired whose pain behaviors 
become blunted, scheduled medications appear to be the best way to manage their pain.  
 
 Male and female participants were nearly equally represented in the study. Also 
the ratio of White to Black enrollees was similar to the United States national average 
with Black enrollees representing nearly 30% of this sample. Hospice enrollees were 
slightly younger than non-hospice enrollees. However, bivariate analysis of nursing home 
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characteristics showed that race was significantly correlated with facility (-.301, p = .025) 
and that hospice was significantly correlated with facility (.337, p = .012). These findings 
suggest that educational efforts to decrease administrative bias that may prohibit hospice 
enrollment may not be working in Western Tennessee. Methods to enroll hospice patients 
based on behavioral cues apparently do not work in the very severely cognitively 
impaired. 
 
 Pain related discomfort behaviors were found to significantly decrease as 
cognitive impairment increases. Bivariate analysis of discomfort behaviors showed that 
race was correlated with DBS scores. Black Americans had significantly higher DBS 
scores. However, as previously mentioned, this difference could be attributed to facility 
bias or it may be contributed to the actual genetic, socio-cultural, or ethnic differences. 
Another reason for this finding could be rater bias when filling out the MDS data 
instrument. Further analysis of this finding showed that the mean total EDU’s were 
nearly identical between Black and White residents. This finding has important 
implications for pain behavior instrument development. Current instruments rarely, if at 
all, make cultural, ethnic, or racial adjustments. Do Black individuals demonstrate 
significantly more pain related behaviors that White individuals? Did Black and White 
older adults in this study receive identical pain relief or were older Black adults 
undertreated for pain? 
 
 A second significant correlation with DBS scores was cancer type. The four 
highest DBS scores in the study were associated with prostate and breast cancer. These 
cancers were identified to have predictably painful metastasis to the bone.  
 
 
RECOMMENDATIONS 
 This study demonstrated that 40% of individuals with malignant cancer and 
dementia were under medicated at the end-of life. Individuals with very severe cognitive 
impairment are more likely to be undertreated for pain and not enrolled in hospice 
services.  
 
 Currently there is no valid and reliable way to assess pain among persons with 
very severe cognitive impairment. This study further demonstrated that total amount of 
pain medication decreased as cognitive impairment increased. This means that self-report 
remains the most valid assessment tool nurses use and when self-report and behaviors 
becomes blunted nursing home residents with malignant cancer and dementia are 
undertreated for pain. The author recommends that new methods be developed for 
assessment of pain among individuals with very severe dementia. 
 
 
FUTURE RESEARCH 
Future studies using individuals with cognitive impairments will require more 
research to discern if the pain pathways are intact. Pain consists of emotional and sensory 
dimensions. Determining how pain affects persons who have the ability to communicate 
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is well established in the literature – it is whatever the person says it is. However, as the 
individual looses the ability to communicate assessment has been difficult and current 
models rely on behavioral assessment and this will not work in the severely cognitively 
impaired 
 
Findings from this dissertation will provide direction for future research and the 
next step is to determine the feasibility of using functional magnetic resonance imaging 
(fMRI) to elucidate the pain pathways among persons with very severe Dementia of the 
Alzheimer’s Type (DAT). Current literature suggests that individuals with DAT have 
pain, but may not be able to express it. Researchers, using fMRI among cognitively intact 
individuals have been able to discern between lateral and medial pain pathways 
demonstrating sensory and emotional pain perception. This means that very severely 
cognitively impaired older adults (CIOA) may be able to feel the pain but be unable to 
verbalize or express it through physical behaviors. We must discern if the pain pathways 
are intact among the very severely cognitively impaired, and if they are, we must change 
the way we currently manage their pain and provide nursing care.  
 
A second area of future research is to determine how the decision is made to 
enroll in hospice. Methods exist to help clinicians determine eligibility for hospice 
enrollment among persons with dementia, however findings from this study show that 
people with severe dementia are not being enrolled.  More research is needed to better 
understand just why this is occurring.  
 
 
POLICY IMPLICATIONS 
 Medicaid is the major payer for long term care and Medicare is the major payer 
for hospice services in the nursing home. Investigators have explained how hospice 
enrollment can save millions of dollars to the Medicare system, yet enrollment continues 
to be a problem. Reimbursement for services, ethical incentives for enrollment, and equal 
reimbursement to nursing homes for hospice are policies that must be implemented in 
order to increase enrollment.  
 
 Individuals with dementia and painful co-morbidities should be given pain 
medications until the time that scientists discern if the pain pathways in dementia are or 
are not intact. A policy change under Medicare would be required to effectively regulate 
pain management in persons who cannot behave or speak.  This means that institutions 
and care providers would not be federally reimbursed unless these individuals receive 
some type of documented pain medication administration.  
 
 New quality measures / indicators in the nursing home or hospital should include 
pain medication administration among residents / patients with dementia. For example, 
admission protocols could be used that provide an easy algorithm for providers to follow 
when an individual is admitted with dementia. Providing choices of scheduled non-
narcotic and narcotic medications with a PRN option then becomes the standard of care 
for individuals who cannot speak or behave normally in pain. A second quality measure 
could be testing the efficacy of the pain medication interventions. This means that 
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individuals with dementia could have their urine and or hair randomly tested to determine 
if the prescribed medications are present. This intervention could be part of the state or 
federal survey and if medications are not present a system of accountability can begin. 
Currently, there is no program in place to administer or monitor the efficacy of 
medication interventions among individuals with severe dementia. 
 
 
MOVING FINDINGS INTO PRACTICE  
 Moving these dissertation findings into practice will require additional research 
on the physiology of dementia and pain in persons with severe dementia. A proposed 
next study will use fMRI to elucidate the pain pathways in persons with severe dementia. 
This technology will hopefully provide evidence that one of not all of the pain pathways 
is intact. This science can then be used to design intervention and outcome studies for the 
very severely cognitively impaired.  
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APPENDIX C. MEDICAL CHART REVIEW FORM 
Subject ID _____ 
LTCF ___________ 
Date  ___________  
Recorder ______ 
 
Pain Assessment and Management Form (PAM)  
 
Dementia Diagnoses (from the medical record) ICD9 codes  
______________________________________________ 
______________________________________________ 
______________________________________________ 
______________________________________________ 
______________________________________________ 
______________________________________________ 
______________________________________________ 
 
Diagnosis of malignant cancer confirmed in the medical record _____ 
Cause of death related to cancer confirmed in the medical record _____ 
Hospice services ❏yes ❏no 
OPIOID ANALGESICS Dose Route
Doses over 
14 days 
Scheduled 
Doses 
PRN  
Doses 
Morphine Sulfate      
Controlled Released Morphine 
(MS Contin, Roxanol SR, 
Avinza) 
     
Hydromorphome (Dilaudid)      
Oxymorphone (Numorphan)      
Levorphanol (Levo-Dromoran)      
Codeine      
Oxycodone (Roxicet, Percocet, 
Percodan, Tylox) 
     
Hydrocodone (Vicodin, Lortab)      
Propoxyphene (Darvocet, 
Darvon, Wygesic) 
     
Meperidine (Demerol)      
Fentanyl (Duragesic)      
Pentazine (Talwin)      
Nalbuphine (Nubain)      
Buprenorphine (Buprenex)      
Other      
Acetaminophen      
Ibuprofen      
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POTENTIATORS 
 
Dose Route Total dose amount 
over last 14 days 
of life 
Scheduled 
doses 
PRN doses 
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